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Abstract
Modulation of surface topography is an effective way to control cellular response and
enhance osseointegration of implants; however it is unclear how surface topography
influences osteoblasts at the molecular level. One of the most frequently observed changes
in cellular behaviour is the organization of the cytoskeleton and actin polymerization which
is regulated by the Rho-family of GTPases. We hypothesized that these GTPases
(specifically Racl and RhoA), play a role in osteoblast response to surface topography and
affect differentiation and mineralization. Osteoconductive rough topographies and nonosteoconductive smooth topographies were used as models to elucidate the roles of Racl and
RhoA. Rat-calvaria derived osteoblasts cultured under Racl inhibition significantly
decreased migration and differentiation and mineralization on rough surfaces. RhoA-protein
associated kinase (ROCK)-inhibition resulted in decreased adhesion formation, and increased
differentiation and mineralization on both surfaces, but did not affect migration. This study
shows that the addition of RhoA-ROCK inhibitors to culture media accelerates osteoblast
differentiation and mineralization in vitro and may represent a new therapeutic to accelerate
healing around implants in vivo.

Keywords
Osteoblasts, Rho GTPases, titanium, topography, mineralization, osseointegration, implants.

in

Co-Authorship Statement
Chapter 2 entitled “Racl and RhoA/ROCK Regulation of Osteoblast Differentiation
on Smooth and Rough Titanium Topographies” was written by P.D.H. Prowse with
suggestions from Drs. S.J. Dixon and D.W. Hamilton.

Experiments were designed by Dr. D.W. Hamilton. All studies were performed by
P.D.H. Prowse. All experiments were carried out in the laboratories of Dr. D.W. Hamilton.

IV

Acknowledgments
I

would first like to thank everyone I have met over the past two years. It has been a

great experience getting to know all of you and I will leave with many fond memories. The
University of Western Ontario has been a wonderful institution to pursue my Master’s
degree.

I would like to acknowledge my supervisors for the help and support they have
provided over the past two years. Thank you for continually encouraging me and developing
my research and critical thinking abilities. Dr. Rizkalla has taught me how to organize and
complete experiments effectively. Dr. Hamilton has taught me the importance of persistence
and attention to detail in research. His guidance has also made me a better presenter and
communicator.

To my friends in the Hamilton lab, I could not have completed this work without you.
Christine’s guidance in cell culture and experience with microscopy was instrumental in
providing the base of knowledge required to complete my experiments. Dr. Weiyan Wen
played a key role in the maintenance of lab operations and expressed interest in my
experiments, offering helpful tips whenever possible. Chris’ undying pursuit of perfection
was a significant motivator for me. From taking me to the lab on days when the busses
weren’t running and the university was closed due to snowfall, to calling me at 8:00am on a
Saturday to get an early start, Chris made work a friendly competition. Chris also acted as a
mentor, proving to be a wealth of knowledge whenever needed. Shawna’s commitment to

research and modesty are at levels we should all strive to achieve. Her scientific knowledge
and friendship has been much appreciated over the past year.

To my friends in the Rizalla lab, your support helped me to maintain a positive
outlook. I would like to thank Deepta, Bedilu, Selma, and Dan for their friendship and help
over the past two years. I have had a great time getting to know you. Dan, your company
has been most welcome and I have thoroughly enjoyed those Hot Italian Sandwiches.

I would also like to thank all the members of the CIHR Group in Skeletal
Development and Remodeling. You are all great people who are willing to help out
whenever necessary. Specifically Emily Leblanc’s encouragement and reminders that life
isn’t just about work were very helpful in controlling stress levels.

I would like to thank my sources of funding: the University of Western Ontario, and
the Joint Motion Program (JuMP) - A CIHR Training Program in Musculoskeletal Health
Research and Leadership.

The role of my family in this research has not been insignificant. Their continued
interest and support kept me grounded and motivated. I really appreciated each of their visits
as they gave me a break from the lab and kept me motivated.

Table of Contents
CERTIFICATE OF EXAMINATION.............................................................................. ii
Abstract....................................................................................................................................iii
Co-Authorship Statement....................................................................................................... iv
Acknowledgments.................................................................................................................... v
Table of Contents................................................................................................................... vii
List of Tables...........................................................................................................................xi
List of Figures........................................................................................................................ xii
List of Appendices (where applicable)............................................................................... xiii
List of Abbreviations............................................................................................................xiv
Chapter 1................................................................................................................................... 1
1 Introduction..........................................................................................................................1
1.1 Chapter Summary........................................................................................................1
1.2 Tooth L oss................................................................................................................... 3
1.3 Periodontal Disease......................................................................................................3
1.3.1

Treatment Options For Tooth Loss................................................................4

1.4 Dental Implants............................................................................................................ 6
1.4.1

Osseointegration............................................................................................ 6

1.5 Bone Biology...............................................................................................................7
1.5.1

Bone Function................................................................................................. 7

1.5.2

Endochondral and IntramembranousOssification......................................... 7

1.5.3

Bone Organization........................................................................................ 10

1.5.4

Bone Composition........................................................................................ 13

1.5.5

Osteoblast Differentiation (Osteocalcin/Runx2)......................................... 18

vii

1.5.6 Bone Healing and the Bone Remodeling C ycle......................................... 22
1.6 Implant Materials.......................................................................................................30
1.6.1

Microtopographies - tools for biology........................................................ 31

1.6.2

Implant T opographies...................................................................................31

1.6.3 Osteoblast Response to Surface Topography..............................................34
1.7 Ras-related Rho GTPases......................................................................................... 40
1.7.1

Cdc42.............................................................................................................40

1.7.2

R a c l............................................................................................................... 41

1.7.3

RhoA..............................................................................................................42

1.7.4

Summary....................................................................................................... 42

1.8 Hypothesis and Objectives........................................................................................43
1.8.1

Overall Hypothesis........................................................................................43

1.8.2 Specific Hypothesis and Objectives............................................................. 44
1.9 References.................................................................................................................. 45
Chapter 2 .........................................................................................

66

2 Role of Racl and RhoA-ROCK Signaling on Osteoblast Differentiation on Smooth
and Rough Titanium Topographies..................................................................................66
2.1 Introduction................................................................................................................ 66
2.2 Materials and Methods.............................................................................................. 68
2.2.1 Preparation of Titanium Surfaces.................................................................68
2.2.2

Osteogenic Cell Culture................................................................................69

2.2.3

Inhibitor Studies............................................................................................ 72

2.2.4

Fluorescent Microscopy............................................................................... 72

2.2.5

Real-time RT-qPCR Analysis...................................................................... 73

2.2.6

Migration........................................................................................................74

2.2.7

Quantification of Mineralization.................................................................. 74
v iii

2.2.8

Scanning Electron Microscopy/Energy Dispersive X-ray Spectroscopy. 75

2.2.9

Statistical Analysis........................................................................................ 75

2.3 Results........................................................................................................................ 76
2.3.1

Effect of Rac 1 and RhoA-ROCK Activity on F-Actin Organization on PT
and SLA .........................................................................................................76

2.3.2

Effect of Racl and RhoA-ROCK on RCO Morphology and Spreading.. 79

2.3.3

Effect of Racl and RhoA-ROCK on Focal Adhesion Formation..............79

2.3.4

Effect of Racl and RhoA-ROCK on RCO Migration................................84

2.3.5

Effect of Racl and RhoA-ROCK on Osteocalcin mRNA......................... 84

2.3.6

Effect of Racl and RhoA-ROCK on Runx2 translocation........................ 89

2.3.7

Effect of Racl and RhoA-ROCK on RCO Mineralization........................ 89

2.3.8

Scanning Electron Microscopy/Energy Dispersive X-ray Spectroscopy. 90

2.3.9

Interaction Effects between Racl and RhoA-ROCK Inhibition and Surface
Roughness..................................................................................................... 97

2.4 Discussion................................................................................................................ 104
2.5 Conclusion............................................................................................................... 108
2.6 Acknowledgements..................................................................:•.............................109
2.7 References............................................................................................................... 112
3 General Discussion......................................................................................................... 116
3.1 Summary and Conclusions..................................................................................... 116
3.2 Contributions to the Current State of Knowledge................................................ 117
3.2.1

General Significance................................................................................. 117

3.2.2

Role of the Cytoskeleton and GTPases in Cell Response to Topography
..................................................................................................................... 118

3.2.3

Role of RhoA-ROCK in Osteogenic Assays............................................ 119

3.2.4

RhoA-ROCK Inhibition for Bone Formation/Healing........................... 119

3.3 Future Directions.....................................................................................................121
ix

3.3.1

Signaling Downstream of Racl and RhoA-ROCK Activity Regulating
Osteoblast Differentiation...........................................................................121

3.3.2

Role of Cdc42 in Osteoblast Morphology and Differentiation................ 122

3.3.3

In vivo Analysis of the Role of GTPases in Secondaryfixation of Titanium
Implants........................................................................................................ 122

3.4 Limitations............................................................................................................... 124
3.5 Final Summary......................................................................................................... 124
3.6 References................................................................................................................ 125
Appendix and Curriculum Vitae..................................................................................... 130

List of Tables
19

Table 1: Non-collagenous proteins

XI

List of Figures
Figure 1 - Natural Teeth and Dental Implants..........................................................................9
Figure 2 - Intramembranous ossification in vivo.....................................................................12
Figure 3 - Histological organization of osteons in cortical bone............................................15
Figure 4 - Differentiation pathways of mesenchymal stem cells........................................... 21
Figure 5 - Development of the rat calvarial osteoblast phenotype in vitro............................23
Figure 6 - Organization of a BMU in trabecular bone............................................................ 27
Figure 7 - SEM of PT and SLA topographies..........................................................................71
Figure 8 - Organization of F-actin on PT and SLA................................................................. 77
Figure 9 - Osteoblast Planar Area............................................................................................ 81
Figure 10 - Focal Adhesion Formation....................................................................................83
Figure 11 - Osteoblast Migration............................................................................................. 86
Figure 12 - Influence of Racl and RhoA-ROCK signaling on osteocalcin mRNA levels ...88
Figure 13 - Runx2 nuclear translocation................................................................................. 92
Figure 14 - Osteoblast biomineralization................................................................................ 94
Figure 15 - Mineralization Quantification.............................................................................. 98
Figure 16 - SEM and EDX analysis of mineral deposits....................................................... 99
Figure 17 - Surface Topography and Focal Adhesion Interactions................................... 101
Figure 18 - Surface topography and osteocalcin mRNA expression interaction............... 103
Figure 19 - Summary of Topography and Inhibitor Effects................................................ 110

xii

List of Appendices
Appendix A: Animal Care and Veterinary Services Protocol Approval

xiii

130

List of Abbreviations
a-MEM

a-minimum essential medium

AA

ascorbic acid

ALP

alkaline phosphatase

AML-3

acute myeloid leukemias

ANOVA

analysis of variance

ATP

adenosine triphosphate

BGP

beta-glycerol phosphate

BMP

bone morphogenetic proteins

BMU

basic multicellular unit

BSA

bovine serum albumin

BSP

bone sialoprotein

CBFA

core binding factor A

co2

carbon dioxide

DAPI

4 ’,6 diamidino-2-phenylindole

DMSO

dimethyl sulfoxide

ECM

extracellular matrix

EDTA

ethylenediaminetetraacetic acid

EDX

energy dispersive x-ray spectroscopy

EMD

enamel matrix derivative

ERK

extracellular-signal regulated kinase

FA

focal adhesion

F-actin

filamentous actin
Xiv

FBS

fetal bovine serum

GDP

guanosine 5’-diphosphate

GTP

guanosine 5’-triphosphate

HA

hydroxyapatite

HC1

hydrochloric acid

HF

hydrofluoric acid

H N 03

nitric acid

H 2 SO4

sulfuric acid

IGF

insulin-like growth factor

M-CSF

macrophage-colony stimulating factor

MAPK

mitogen-activated protein kinase

MLC

myosin light chain

MMP

matrix metalloproteinase

mRNA

messenger RNA

MSC

mesenchymal stem cell

OC

osteocalcin

ON

osteonectin

OP

osteopontin

Osx

osterix

PAK

p-21 activated kinase

PBS

phosphate-buffered saline

pge2

prostaglandin E2

PI3-K

phosphoinositide-3-kinase

PT

polished titanium
XV

Ra

surface roughness

RANK

receptor for activation of nuclear factor kappa-B

RANKL

receptor for activation of nuclear factor kappa-B ligand

RCO

rat calvarial osteoblast

RNA

ribonucleic acid

ROCK

RhoA-protein associated protein kinase

RT-qPCR

reverse transcription-quantitative polymerase chain reaction

Runx2

runt-related transcription factor 2

SE

standard error of the mean

SEM

scanning electron microscopy

SLA

sand blasted with large particles followed by acid etching

TGF-p

transforming growth factor-P

TPS

titanium plasma sprayed

XVI

Ra

surface roughness

RANK

receptor for activation of nuclear factor kappa-B

RANKL

receptor for activation of nuclear factor kappa-B ligand

RCO

rat calvarial osteoblast

RNA

ribonucleic acid

ROCK

RhoA-protein associated protein kinase

RT-qPCR

reverse transcription-quantitative polymerase chain reaction

Runx2

runt-related transcription factor 2

SE

standard error of the mean

SEM

scanning electron microscopy

SLA

sand blasted with large particles followed by acid etching

TGF-p

transforming growth factor-p

TPS

titanium plasma sprayed

XVI

1

Chapter 1
1

Introduction

1.1

Chapter Summary
Due to the aging North American population, and increased life expectancy, the
market for tooth replacements is expected to increase (Douglass et al., 2002).
Current treatments for tooth loss such as partial bridges and dentures can affect
neighbouring teeth and can potentiate further bone loss (Cibirka et al., 1997;
Creugers et al., 2000). Titanium dental implants represent the most suitable
treatment for tooth loss, as titanium is known to form a direct interface with bone,
and these implants have a minimal impact on surrounding teeth. However,
implants still often fail due to inexperienced operatives, infections, immediate
loading, and poor bone quality (Esposito et al., 1998). Various strategies have
been employed to reduce the failure rates of implants, of which topographical
modifications have had considerable success. Roughened implant surfaces tested
in vitro demonstrated an increase in osteoblast differentiation and

biomineralization, (Bachle and Kohal, 2004; Larsson et al., 1996; Lincks et al.,
1998; Martin et al., 1996) which also translated to increased bone formation when

the same surfaces were placed in vivo (Gotfredsen et al., 1992). It has also been
well documented that surface topography affects cytoskeletal organization of
cultured osteoblasts (Anselme et al., 2000; Kieswetter et al., 1996; Liithen et al.,
2005). Cytoskeletal organization and F-actin polymerization are regulated by the

2

Rho-family of GTPases (Nobes and Hall, 1995; Ridley and Hall, 1992; Ridley et
al., 1992), of which the most thoroughly characterized are Cdc42, Racl, and
RhoA. We hypothesized that topographical regulation of osteoblast
differentiation and mineralization is regulated through Racl and RhoA activity.

3

1.2 Tooth Loss
Tooth loss remains a significant clinical concern in North America and, although rates of
tooth loss have been decreasing in the last 30 years, large discrepancies still exist in the
rates of edentulism (tooth loss) between socio-economic classes within the United States
and Canada. As of 2001, edentulism rates as high as 13.9% were observed in low socio
economic classes and 2.5% in the high socio-economic classes (Cunha-Cruz et al., 2007).
These rates were also related to age group, with edentulism rates as high as 43.4% in
patients aged 65-74 in low socio-economic classes. Apart from social status, other risk
factors for tooth loss include smoking and occupation (Chambrone et al., 2010; Muller et
al., 2007).

1.3 Periodontal Disease
Periodontal disease is a major contributor to tooth loss and results most commonly from
poor dental hygiene (Albandar and Rams, 2002). It can begin as gingivitis, which is
characterized by chronic inflammation of the gums due to bacteria which have infiltrated
the gingival epithelium connective tissue. Untreated, gingivitis can cause the destruction
of the supporting alveolar bone which is an indicator of periodontitis (Nguyen and
Martin, 2008). Tooth loss results as a consequence of excessive alveolar bone
degradation due to bacterial infiltration down the side of the cementum (Nguyen and
Martin, 2008).

4

1.3.1

Treatment Options For Tooth Loss

Various treatments are available for replacement of secondary teeth including resin
bonded fixed partial dentures, full dentures, conventional bridgework, and dental
implants (Jung et al., 2008; Patel et al., 2010). This decision on which treatment is
utilized is based on several criteria including bone density, oral hygiene, and levels of
apical periodontitis, since these are determinants in the overall success of the restoration
after implantation (Jung et al., 2008). Although each treatment has advantages and
disadvantages, implants are considered superior to dentures and bridgework due to their
higher survival rates, low impact on neighbouring teeth, and effect on improving quality
of life (Cibirka et al., 1997; Creugers et al., 2000).

Early implant-supported crowns had low success rates and many were not recommended
for clinical use (Albrektsson et al., 1986). Through trial and error, successful procedures
for implant placement were subsequently developed. The initial step in implant
placement involves drilling a hole at the location of implant placement. The intraosseous
component of the implant is screwed into the bone and left to heal unloaded for 6-8
weeks so that sufficient bone can form around the implant to support functional loading.
The intraosseous component interfaces directly with the cortical and trabecular bone and
is responsible for transducing mechanical forces to the jaw (Figure 1). After the stressfree healing period, the transmucosal component (abutment) is attached to the submerged
implant so that a prosthetic crown can be attached. The transmucosal portion of the
implant interfaces with the gingival tissue (gingival connective tissue and oral
epithelium) with which it must form strong contact (Figure 1). This is necessary to
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prevent peri-implant infection (Lloyd et al., 1997) which compromises bone healing
around the implant and often results in implant avulsion (Esposito et al., 1998; Misch et
al., 2008).

By 2000, implant survival rates as high as 97% after 4 years were reported, although up
to 20% of these implants required some type of intervention to ensure continued implant
survival (Creugers et al., 2000). As of 2007, survival rates were 97% up to 6 years
(Torabinejad et al., 2007). Despite the increasing lifespan and long term success of
dental implants (Muller et al., 2007), the US market for implants is expected to rise due
to an aging baby boomer population and increased life expectancy (Douglass et al.,
2002). Moreover, an increasing number of implants are failing due to poorly trained
operatives, inappropriate placement, immediate loading, and systemic conditions such as
diabetes and osteoporosis. While implants should not be placed in areas of poor bone
quality or in people who exhibit delayed healing, new surface topography modification
techniques may help promote bone healing even in these non-ideal situations. The cell
and molecular events required for implant-bone bonding is still not fully understood, and
remains an area that needs to be further investigated in order to enhance implant
secondary stabilization after implantation as well as to achieve long-term integration with
the surrounding bone.
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1.4 Dental Implants
1.4.1

Osseointegration

Osseointegration is the intimate functional interface between an implant and bone tissue
where no intermediate fibrous tissue layer exists between the bone and the implant
surface (Branemark et al., 1969; Branemark et al., 1997; Listgarten et al., 1991; Schenk
and Buser, 1998). Functionally, a successful implant will support normal loads
experienced during mastication (chewing) without pain or loosening (Esposito et al.,
1998). As an implant is placed in the jaw it is supported by cortical bone and trabecular
bone, which provides the primary interface and anchor for the implant. Peri-implant
infection, pain or sensitivity, radiographic bone loss, and mobility are parameters
commonly used to evaluate implant failure (Esposito et al., 1998). Although several of
these parameters may indicate poor osseointegration, implant mobility is the most reliable
parameter for determining fixation as it clearly demonstrates the failure of the
intraosseous component to bond with the surrounding osseous tissue (Esposito et al.,
1998). Of the implants that fail prior to functional loading, 50% do so as a result of a
failure to osseointegrate (Jung et al., 2008).

Successful placement and integration of a dental implant depends on obtaining primary
stability (Calandriello et al., 2003; Meyer et al., 2004) and maintaining an infection-free
environment so that the bone can heal (O’Sullivan et al., 2000). During the 6-8 week
stress-free healing period, the implant is of no functional use and occlusal forces are lost
for the opposing tooth which often has detrimental effects (Calandriello et al., 2003).
Thus, accelerating bone healing around implants to achieve faster osseointegration and
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reduce the stress-free healing period would be of major clinical significance. Several
approaches have been developed to enhance osseointegration, which will be discussed in
detail later in the chapter. However, it is first necessary to understand the biology of
bone, its remodeling and healing, as this is critical to which aspects of osteoblast
behaviour can be targeted to enhance osseointegration.

1.5 Bone Biology
1.5.1

Bone Function

Bone is a highly dynamic and vascularized tissue that serves several important functions
in the body. It acts as protection for vital organs, a support structure for muscles, housing
for bone marrow, and a reservoir for calcium, magnesium, and phosphate ions
(Kronenberg, 2003; Marks and Popoff, 1988). Additionally in the jaw, it provides
support for teeth to distribute large stresses experienced during mastication. Upon
placement of an implant, the bone is damaged which necessitates debridement, bone
formation (intramembranous ossification), followed by remodeling. These processes and
their underlying molecular regulation are described below.

1.5.2

Endochondral and Intramembranous Ossification

During development, bone formation occurs through either endochondral or
intramembranous ossification. The majority of bones form via endochondral ossification
in which a cartilaginous template is replaced by bone (Kronenberg, 2003). Endochondral
ossification occurs during development and through adolescence to increase the length of
our bones through ossification of chondrocytes at the growth plate.

8

Figure 1 - Natural Teeth and Dental Implants: There are several differences between

a natural tooth and a dental implant. During tooth replacement surgery, the periodontal
ligament is removed along with the tooth. Part of the new implant interfaces directly
with the jaw bone and must facilitate bone formation in order to be successful. The
implant abutment interfaces with the gingival tissue and this interface plays a critical role
in the success of the implant as it prevents microbes from infiltrating the underlying bone
and causing an infection, which would impair healing.
http://www.morganheightsdental.ca/dental implants.html. Accessed November 19,
2011.
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However the majority of the skull bones and part of the clavicles develop through
intramembranous ossification in which mesenchymal stem cells (MSCs) differentiate
directly into osteoblasts without a cartilaginous intermediate stage (Figure 2) (Karsenty
and Wagner, 2002).

Both types of bone formation are initiated by the condensation of MSCs. In
intramembranous ossification, the MSCs form a template through proliferation of the
osteoprogenitors prior to their differentiation into osteoblasts (Caplan, 1991). The initial
extracellular matrix (ECM) deposited is disorganized and structurally weak. Over time,
this ECM mineralizes and the bone is remodeled in response to load to form a denser,
more organized bone structure (Cowles et al., 1998).

1.5.3

Bone Organization

Bone tissue is a highly organized tissue classified as either trabecular (spongy,
cancellous) or cortical (dense, compact) depending on its organization at the macro level.
Trabecular comes from the Latin word trabecula which means “small beam” and this
bone is characterized by high porosity and low density. It is found around the marrow
cavity of long bones and sandwiched between two layers of cortical bone in the flat bones
of the skull (Rho et ah, 1998). Dense compact bone also forms the hard exterior of long
bones, giving them their smooth, white appearance. Several different levels of
organization exist within bone at each of the macro, micro, and nano-scale. On the
macro-scale, trabecular and cortical bone can be easily distinguished by their difference
in porosity.
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Figure 2 - Intramembranous ossification in vivo: Intramembranous ossification as

stained with hematoxylin and eosin. Top figure illustrates a coronal section of
intramembranous ossification occurring in the skull. Note the formation of bone in many
individual locations. These will eventually join to form the flat bones of the skull. The
lower figure is a higher magnification image of one of the ossifying centres. Note how
the osteoblasts surround the bone to deposit osteoid which subsequently mineralizes.
This occurs directly from MSC condensation without the formation of a cartilaginous
template as in endochondral ossification.
https://secure.health.utas.edu.au/intranet/cds/caml02/Practicals/06.Week%209%20%20Histologv%20of%20the%20Growth%20of%20Bones.html. Accessed November 19,
2011.
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This is reflected in the mean density of each bone type (1.08 g/cm for trabecular vs. 1.85
g/cm for cortical bone (Blanton and Biggs, Norman, 1968)). The microstructure of both
trabecular and cortical bone is comprised of layers of mineralized collagen which are
organized into lamellae 3-7 pm in width (Rho et al., 1998). In trabecular bone, lamellae
surround existing trabeculae to reinforce the structure in response to mechanical stress
according to W olffs Law. This law suggests that the bone tissue will be reorganized in
response to load to reduce the strain induced by that load. In cortical bone, lamellae
organize themselves into concentric layers creating a Haversian canal containing a blood
vessel. Each individual Haversian canal surrounded by several layers of collagen sheets
is known as an osteon. Cortical bone is comprised of many osteons, each 10-500 pm in
diameter, in intimate contact with each other (Figure 3).

1.5.4

Bone Composition

Bone is a composite material made of cells and an ECM consisting of inorganic and
organic components, both of which contribute independently to bone’s function as a

tissue. Synthesis and organization of the ECM and mineral is regulated by the bonesynthesizing and bone-resorbing cells: osteoblasts and osteoclasts respectively. In the
context of osseointegration, both cell types play an important role in the successful
integration of the implant with the host bone.

1.5.4.1

Cellular Component

Two distinct progenitor stem cell lineages are responsible for the development of all the
different cell types found within bone tissue.
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Figure 3 - Histological organization of osteons in cortical bone: Note the overlapping

of the osteon encircled with green and the osteon encircled with orange. The presence of
the Haversian canal in the green-circled osteon and the lack of a canal in the orange
osteon indicate that the green osteon is newer. During remodeling, the orange-circled
osteon was partially resorbed to make way for new bone. Image adapted from
http://lh3.ggpht.com/ NE4H vDtRns w/R9M91B vfM71/AA AA AA A AAmE/n47 u vVZU i9 g
/Interstitial%20Lamellae%20in%20Ground%20Bone.png Accessed: November 19,
2011.
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MSCs give rise to osteoblasts which synthesize bone matrix. The flattened, quiescent
bone-lining cells on the exterior of bone surfaces (Marks and Popoff, 1988) are also
derived from this lineage and can be activated as osteoblasts during remodeling. As
osteoblasts produce matrix, a portion of the osteoblasts become entrapped in the matrix
and terminally differentiate into osteocytes (Marks and Popoff, 1988).

The second progenitor cell population arises from a hematopoietic lineage. This lineage
gives rise to osteoclasts, which are responsible for matrix and mineral degradation.
Within the sealing zone beneath an osteoclast, proton pumps produce hydrochloric acid
(HC1) to reduce the pH (pH ~ 3) which facilitates the dissolution of the hydroxyapatite
(HA) crystals (Vaananen et al., 2000). Proteases such as collagenase (matrix
metalloproteinase I; MMP-1), gelatinase B (MMP-9), and cathepsins (mainly cathepsin
K) are also released from these cells in order to degrade the bone matrix (Everts et al.,
1992; Goto et al., 2003; Page et al., 1993; Radding et al., 1994; Silver et al., 1988;
Vaananen et al., 2000). Osteoblasts and osteoclasts work in concert to maintain bone’s
structure by secreting and degrading the matrix in response to mechanical load as well as
systemic calcium and phosphate levels (Harada and Rodan, 2003; Rodan and Martin,
1981). Each cell type exhibits very distinct phenotypes that are associated with their
specific differentiated function in mature bone.

1.5.4.2

Organic Component

The organic constituents of bone account for 24-26% of its wet weight (Stack, Maurice,
1955) and consist mainly of type I collagen with smaller amounts of types III (Keene et
al., 1991), V, XI, XIII, and XXIV collagen. It also contains proteoglycans, serum

proteins, lipids, and other non-collagenous proteins including bone sialoprotein (BSP),
osteocalcin (OC), osteopontin (OP), and osteonectin (ON) (Marks and Popoff, 1988).
Non-collagenous proteins make up about 5% of the dry weight of bone. Water makes up
another 5-10% (Hauschka and Wians, 1989).

Type I collagen is the most abundant organic component of bone comprising 90% of the
organic mass (Gelse, 2003). Collagen I fibrils are structurally organized to provide
increased toughness and tensile strength in bone (Gelse, 2003; Peterlik et al., 2006;
Viguet-Carrin et al., 2006). Type I collagen consists of three subunits, two a l units and
one a 2 unit, which self-assemble to form a triple helix after several post-translational
modifications (Viguet-Carrin et al., 2006). Disruption of this triple-helix structure is
known to cause several pathologies (Baum and Brodsky, 1999; Kuivaniemi et al., 1997),
including osteogenesis imperfecta which results in brittle bones, abnormal teeth
colouration and increased tooth wear (Myllyharju and Kivirikko, 2001; Sillence et al.,
1979) . In vitro studies have highlighted that type I collagen is important not only for

strength, but it also influences cell behaviour. It is now known that type I collagen
promotes osteoblast adhesion (Geissler et al., 2000), migration, proliferation (Schor,
1980) , and differentiation. Surfaces coated with type I collagen also help to maintain
osteoblast phenotype in culture (Lynch et al., 1995).

The four most common non-collagenous proteins OP, BSP, OC, and ON play several
roles in bone development including regulating matrix mineralization, cell adhesion, and
recruitment of osteoclasts (Hauschka and Wians, 1989; Nilsson et al., 2005). OP and
BSP are present prior to bone mineralization, suggesting that these proteins could be

regulators of mineralization, whereas OC and ON are only present after mineralization
has begun (Roach, 1994). Table 1 details the function of each of these proteins and the
phenotype of the associated knockout mouse.

1.5.4.3

Inorganic Component

Hydroxyapatite makes up the inorganic component (Wopenka and Pasteris, 2005) and
constitutes approximately 60% of compact bone by wet weight. Hydroxyapatite also acts
as a reservoir for calcium and phosphate ions which helps to maintain blood calcium ion
homeostasis as bone can be resorbed to release calcium is response to parathyroid
hormone (Carafoli, 1987). The apatite in bone is a calcium and hydroxide deficient
carbonated HA, but the chemical formula is often reported as Caio(P0 4 )6 (OH ) 2 since this
is the formula for the HA unit cell. Changes in the chemical makeup of apatite result in
changes in crystal shape and growth. The carbonated HA in bone has a plate-like
morphology which is suited to interface with collagen fibrils (Peterlik et al., 2006;
Weiner and Traub, 1992; Wopenka and Pasteris, 2005). This facilitates the
reinforcement of collagen fibrils with HA and allows bone to resist large tensile stresses
(Peterlik et al., 2006). HA deposition and mineralization of osteoblast cultures is the
final stage during in vitro differentiation correlating with osteoblast maturation.

1.5.5

Osteoblast Differentiation (Osteocalcin/Runx2)

During the process of osteoblastogenesis and osteoblast maturation, a variety of proteins
and transcription factors are expressed which are characteristic of the different states of
osteoblast maturation (Figure 4). One of the main regulators of osteoblast differentiation
is Runx2.

Table 1: Non-collagenous proteins found in bone
Protein

Function

Knockout Mouse
Phenotype

Delays mineral deposition to prevent
mineral other than HA from being
deposited
Chemotactic (Rodan, 1995)
Facilitates osteoclast adhesion (Reinholt
et al., 1990; Roach, 1994)
Associates with collagen and HA
inducing mineral nucleation (Hunter and
Goldberg, 1993)
Facilitates osteoclast adhesion (Roach,
1994)

Normal skeleton
ultrastructure (Rittling et
al., 1998)
Î Mineral content
t Crystallinity
(Boskey et al., 2002)

Osteonectin •

Nucleation of HA and organization with
ECM (Roach, 1994)

Osteocalcin

Binds to calcium forming an a-helix and
may play a role in mineralization
(Hauschka and Wians, 1989)
Chemotactic (Chenu et al., 1994)

i Bone mass
{ Bone turnover
1 Osteoblasts
l Osteoclasts
(Delany et al., 2000; Delany
et al., 2003)
Î Mineral content (Boskey
et al., 2003)
Î Bone formation
Î Mineralization
(Boskey et al., 1998; Ducy
et al., 1996)

Osteopontin •

•
•
Bone
•
Sialoprotein
•

•

•

l Body size
[ Bone turnover
i Collagen I
i Osteocalcin
(Malaval et al., 2008)
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Figure 4 - Differentiation pathways of mesenchymal stem cells: Mesenchymal stem

cells give rise to myocytes, adipocytes, chondrocytes, and osteoblasts. The commitment
of these cells to each lineage and terminal differentiation of that cell type is dependent on
a variety of signaling molecules as demonstrated in this schematic. Runx2 and Osterix
(Osx) are the two transcription factors critical for osteoblast differentiation. As the
mesenchymal progenitors undergo osteoblast differentiation they express a different
profile of proteins. During the proliferation stage, osteoblasts express high levels of
transforming growth factor-(3 (TGF- pi), Runx2, and collagen I. As the cells differentiate
into pre-osteoblasts they begin to produce matrix and are characterized by high levels of
ALP and collagen I. Terminal differentiation of osteoblasts and mineralization is
characterized by high levels of OC and BSP, but also expression of collagen I, and ALP.
Figure modified from Harada and Rodan (2003).
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As a member of the Runx family transcription factors, Runx2 (CBFA1, AML-3)
possesses a DNA-binding domain which is homologous to the Drosophila gene runt
(Kania et al., 1990). Although Runx2 is responsible for MSC differentiation towards an
osteogenic lineage, it ultimately inhibits mature osteoblast differentiation (Komori,
2006). Runx2 knockout mice possess low alkaline phosphatase (ALP), OP, and OC
levels (Komori et al., 1997) as Runx2 plays a critical role in regulating transcription of
OC (Bidwell et al., 1993; Merriman et al., 1995), OP, and type I collagen. Expression of
Runx2 in other cell types results in the transcription of osteoblast-related genes
confirming its role in regulating osteoblast differentiation (Karsenty et al., 1999).

OC is considered a late marker of osteoblast differentiation (Komori, 2006; Wada et al.,
1998). It contains 3 vitamin K dependent y-carboxyglutamate residues which bind to
calcium and HA (Hauschka and Reid, 1978; Hauschka and Wians, 1989). Although its
precise function is not known, its expression is correlated with terminal differentiation of
osteoblasts at the onset of mineralization (Lian et al., 1989) (Figure 5), Terminal
differentiation of osteoblasts into osteocytes results as osteoblasts become embedded in
bone matrix. However, the osteocytes maintain communication with other osteocytes
and surface osteoblasts via gap junctions in small channels throughout the bone known as
canaliculi (Civitelli, 2008). This allows them to transduce mechanical stresses into
signals that result in the initiation of remodeling (Lanyon, 1993).

1.5.6

Bone Healing and the Bone Remodeling Cycle

During implant placement a defect has to be created in order to insert the intraosseous
component of the implant.
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Figure 5 - Development of the rat calvarial osteoblast phenotype in vitro: Osteoblasts

in culture exhibit different timelines of protein expression depending on the source of the
osteoblasts. Rat calvarial osteoblasts initially express high levels of collagen I which
declines as the cells mature. Proliferation ends during the matrix maturation phase,
around the same time as the peak levels of ALP. The onset of matrix mineralization
correlates with peak expression of OC (Siggelkow et al., 1999).
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In response to the injury created through the surgical procedure, inflammation occurs,
osteoclasts are formed to resorb damaged bone, and finally osteoprogenitor cells are
recruited to synthesize new bone. This process recapitulates intramembranous
ossification (described in section 1.5.2). The new mechanical stresses imposed by the
implant also activate the bone remodeling cycle. The process of bone remodeling
consists of four phases: activation, resorption, reversal, and formation (Harada and
Rodan, 2003). The coordination of osteoclasts and osteoblasts in reorganizing the
structure of bone is known as a basic multicellular unit (BMU) (Figure 6 ). In cortical
bone, the BMU forms a tunnel as the osteoclasts degrade the matrix and form the leading
edge of the BMU. In trabecular bone, the structure of the BMU is the same; however
remodeling occurs only on the surface of the trabeculae.

1.5.6.1

Activation

During activation, a quiescent layer of bone-lining cells is disrupted and osteoclasts
attach to the exposed surface. In order for this to occur, mononuclear osteoclast
precursor cells are recruited to the site of remodeling and fuse to become osteoclasts
(Marks and Popoff, 1988; Roodman, 1999; Schenk et al., 1997; Udagawa et al., 1990).
Osteoclastogenesis is primarily regulated by two molecules: macrophage-colonystimulating factor (M-CSF) and Receptor for Activation of Nuclear factor kappa-B
(RANK) ligand (RANKL), but is also affected by interleukin 1 and 11, vitamin D 3 , and
prostaglandin E 2 (PGE2 ) (Ito et al., 2010; Matsuo and Irie, 2008; Teitelbaum, 2000). As
the osteoclast differentiates, it becomes activated, and survives for an extended period of
time. The overall in vivo survival rates of osteoclasts are still not known.
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Figure 6 - Organization of a BMU in trabecular bone: The bone remodeling cycle is

initiated by the recruitment and fusion of haematopoietic stem cells to form
multinucleated osteoclasts. During the resorption phase osteoclasts secrete acids and
proteases such as cathepsin K to degrade the mineral and matrix. In the reversal phase
mononuclear cells are present, such as macrophages which act to prepare the bone
surface for new bone formation. During the formation phase osteoid is synthesized and
mineralized by osteoblasts to replace the old bone. During bone formation some
osteoblasts will become embedded in the matrix and terminally differentiate into
osteocytes, while those that remain on the surface will become quiescent bone-lining
cells. Within cortical bone, this process is mirrored on the other side to form a tunnel
through which remodeling occurs.
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1.5.6.2

Resorption

The resorption phase begins as fully differentiated osteoclasts begin to break down the
bone matrix. This involves the secretion of tartrate-resistant acid phosphatase and
cathepsin K, the latter representing a major protease responsible for degrading bone
matrix (Goto et al., 2003; Littlewood-Evans et al., 1997). In the case of implant
placement, osteoclasts are recruited to the site of injury and engulf the bone debris in the
surrounding area, while preparing the bone surface for new bone formation (Colnot et ah,
2007). After approximately 2-3 weeks the resorption phase ends as the osteoclasts
undergo apoptosis (Hadjidakis and Androulakis, 2006; Harada and Rodan, 2003).

1.5.6.3

Reversal

The reversal phase is characterized by the presence of mononuclear cells which may be
monocytes, newly recruited osteoblasts, or osteocytes released from within the bone
matrix (Baron et ah, 1980; Lanyon, 1993; Oguro and Ozawa, 1989; Tran Van et ah,
1982). This phase may last as long as 4-5 weeks. In order to initiate the formation
process, signaling molecules are released during reversal (Zhao et ah, 2006), which
recruit pre-osteoblasts to the remodeling site. These molecules include carbohydrates,
lysosomal enzymes (Romano et ah, 1997), and various growth factors, such as TGF-P
(Pfeilschifter and Mundy, 1987), bone morphogenetic proteins (BMPs), and insulin-like
growth factor II (IGF-II) (Matsuo and Irie, 2008). The transition from resorption to
reversal to formation results in the formation of a cement line which delineates the old
bone from that of the newly deposited bone matrix (Romano et ah, 1997).
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1.5.6.4

Mineralization

The final stage of bone remodeling involves the deposition of osteoid and its subsequent
mineralization. During matrix deposition, a portion of the matrix-secreting osteoblasts
become entrapped in the bone and become osteocytes. These osteocytes may play a role
in signal transduction throughout the tissue (Lanyon, 1993; Mullender and Huiskes,
1995) by communicating changes in mechanical properties and stresses. This facilitates
bone formation in response to stresses according to W olffs Law (Davies, 1998; Davies,
2003; Huiskes et al., 1987). To completely replace the resorbed bone, the formation
phase may last as long as 4 months (Hadjidakis and Androulakis, 2006).

Increasing the rate and amount of bone formed around dental implants is an issue with
clinical significance and has been an area of considerable research. As already stated,
during the stress-free healing period after placement of the intraosseous component, the
occlusal forces are lost on the teeth opposing the implant. The longer this period is, the
more detrimental effects there are for these opposing teeth. Of particular concern is
breakdown of the periodontal ligament structure. Therefore, reducing the length of time
required for integration of the intraosseous is, from a clinical standpoint, highly desirable.
To do this, most research has focused on the engineering of the bone-implant interface,
primarily by changing the chemistry and topography of the implant surface.

1.6

Implant Materials

Since the inception of regenerative medicine, which can be traced back to the Mayans,
the ancient Egyptians and the Romans, many different materials have been used to
support and replace injured tissues. A large variety of metals and metal alloys used have
been tested including gold, silver, iron, lead, bronze, steel, platinum, tantalum, hafnium,
niobium, rhenium, zirconium, cobalt-chromium, and titanium (Branemark et al., 1969;
Matsuno et ah, 2001; Neailey and Pond, 1982). However many of these materials are not
suitable for use in a biological environment due to their mechanical properties and/or
toxicity. Titanium and its alloys have been used for bone-contacting implants since the
1980s due to their high biocompatibility, low corrosion, and most comparable elastic
modulus to bone versus to other implant materials (Parr et ah, 1985). As a result of its
superior biological properties, many alloys of titanium have been created in an attempt to
decrease its melting point and increase its castability (Bagno and Di Bello, 2004; Lloyd et
ah, 1997). In vivo, titanium forms a direct interface with bone tissue (Albrektsson et ah,
1983; Albrektsson et ah, 1981; Albrektsson et ah, 1985; Branemark et ah, 1983;
Branemark et ah, 1969; Linder et ah, 1983; Matsuno et ah, 2001; Meyer et ah, 2004).
Interestingly, the formation of bone around titanium can be further enhanced by
modifying the surface topography of the implant surface (Coelho et ah, 2009; Suzuki et
ah, 1997; Wennerberg and Albrektsson, 2009).
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1.6.1

Microtopographies - tools for biology

In order to effectively analyze cellular responses to topography, artificial materials were
constructed with highly defined features. These structures facilitated the study of cell
response to various surface features such as steps, pits (Hamilton et al., 2007), columns
(Bettinger et ah, 2009), grooves (Hamilton et ah, 2009; Walboomers et ah, 1998), and
discontinuous edges (Hamilton et ah, 2006). Although useful for observing cellular
response to topography alone, microfabricated surfaces are very difficult and would be
prohibitively expensive to create on clinically used implants and thus are not relevant for
clinical applications.

1.6.2

Implant Topographies

Modifications of implant surfaces are easy to produce through processes in which the
topographical features formed are random in size and spacing. These processes include
machining, polishing, grit blasting, acid etching, and titanium plasma spraying (Le
Guéhennec et ah, 2007). However, in some cases, multiple processes are combined to
create unique surface features such as Sand-blasting with Large grit and Acid etching,
which is used to form the SLA surface.

In order to quantitatively compare the roughnesses of different surfaces, several
parameters have been identified which attempt to describe the different features of these
topographies (Wieland et ah, 2001). One of the most commonly used parameters is the
average roughness (Ra) value which is defined as the arithmetic average of the absolute
values of all points on a one-dimensional profile of the surface. This is also known as the
centreline average height.
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m

i= 1

Where z is the height of each individual point (xi) along a one-dimensional profile
of the surface.

1.6.2.1

Machined Topographies

Early implant topographies resulted from machining the surface of the implant to create
the desired macro-level implant shape. This would include creating threads for the
implant. These modifications are typically made with a carborundum disk saw or a
stainless steel cutting tool (Bagno and Di Bello, 2004). Implants with machined surfaces
display concentric grooves as a result of the rotating saw and have a few surface defects
(Massaro et al., 2002) which increase the surface hardness of the implant. Machined
implants have low roughness values of about Ra=0.3-0.6 (Bagno and Di Bello, 2004).

1.6.2.2

Rough Topographies

A variety of methods have been used to increase the roughness of implants at both the
nano- and micro-metric scale. These include grit blasting, acid etching, and titanium
plasma spraying. Grit blasting is the process of projecting particles at the implant surface
using high-velocity compressed air. Depending on the size and type of particle used a
variety of surface defect sizes and roughnesses can be created (Aparicio et al., 2003;
Bagno and Di Bello, 2004; Le Guéhennec et al., 2007; Mustafa et al., 2001). Alumina,
titanium oxide, glass, corundum, and HA are a few commonly used particles for grit
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blasting. Although grit blasting increases surface roughness, it likely only increases the
mechanical fixation of the implants, but does not promote biological fixation since it
lacks sub-micron roughness (Zinger et al., 2005). One disadvantage of grit blasting is the
possibility of the blasting particles becoming embedded in the implant surface which can
affect osteogenesis (Le Guehennec et al., 2007). Removal of these particles from the
implant cannot always be achieved and they can be released into the surrounding tissue
beds after implantation resulting in inflammation and osteolysis (Le Guehennec et al.,
2007; Steinemann, 1996).

Commonly used acids for etching include hydrochloric (HC 1), sulfuric (H2SO4), nitric
(HNO3), and hydrofluoric (HF) acid and can be used at room temperature or higher

(Bagno and Di Bello, 2004; Le Guehennec et al., 2007). Acid etching modifies the
microstructure of implants by creating micropits which can vary in size between 0.5 and
2.0 micrometers in diameter (Massaro et al., 2002; Zinger et al., 2004). Since acid
etching creates such small topographical features, it can be utilized to create an additional
level of roughness on top of an existing topography (Bagno and Di Bello, 2004).

Through a combination of grit blasting and acid etching, Institut Straumann AG
developed the Sand-blasted, Large grit, and Acid etched (SLA) topography. Hierarchical
levels of roughness are created as a result of the two processes: large defects 20-50 pm
occur as a result of sand blasting, and smaller micropits 0.5-2 pm in diameter result from
HCI/H2 SO4 treatment (Massaro et al., 2002; Wieland et al., 2005). This topography is
similar to that of osteoclast resorption pits which may be the most effective size range for
stimulating osteoblasts to form bone (Zinger et al., 2005). The particles used for blasting
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range in size from 250-500 pm in diameter (Buser et al., 2004). The Ra value for SLA
surfaces is about 4 jam (Bannister et al., 2002; Brett et al., 2004; Schwartz et al., 2001).

The techniques discussed thus far are subtractive methods for creating rough
topographies. However, such topographical features can also be produced through
additive methods such as titanium plasma spraying. This involves increasing the
roughness of the implant surface by adding a coating of randomly organized and
dispersed titanium particles. This is done by volatilizing a titanium powder using a
15000°C argon plasma flame and spraying it onto the implant surface (Babbush et al.,
1986). The final thickness of the titanium layer created through this method is 40-50 pm
(Babbush et al., 1986) and has a high average Ra value ranging between 5.21-7.00 pm
(Bagno and Di Bello, 2004; Bannister et al., 2002; Brett et al., 2004; Klokkevold et al.,
2001). Titanium plasma spraying results in a cracked surface, and has large spherical
droplets of deposited titanium (Bagno and Di Bello, 2004). This layer of titanium
increases the surface area of the implant (Coelho et al., 2009) while creating what has
been called an “open-porous” structure (Babbush et al., 1986; Massaro et al., 2002)
which facilitates bony ingrowth. However, it is known that the titanium particles can be
shed from the surface making this type of implant surface less desirable from a clinical
standpoint.

1.6.3

Osteoblast Response to Surface Topography

Topographical regulation of osteoblast behaviour has been well established in many
studies both in vitro and in vivo. Rougher surfaces have been demonstrated to increase
osteoblast attachment, differentiation, and biomineralization (Bachle and Kohal, 2004).
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Conversely, smooth topographies promote adhesion formation, spreading, and
proliferation. Therefore, by controlling the topographical features on the implant surface,
it is possible to influence osteoblast behaviour that results in differentiation and
biomineralization. Although different hypotheses have been postulated, topographic
modulation of osteoblast adhesion is the first step.

1.6.3.1

Attachment

In order for cells to interact with a biomaterial, they must first attach to it. This is a
crucial step in the colonization of the biomaterial and is governed by the type of proteins
that adsorb to the surface of the implant (Davies, 1998; Siebers et al., 2005; Trisi et al.,
2003). Transmembrane proteins known as integrins are responsible for cell adhesion, and
facilitate interaction of the cell with the layer of proteins adsorbed to the implant surface
(Anselme, 2000). Topographical mediation of cell adhesion is caused by differences in
protein adsorption due to changes in surface energy (Di Iorio et al., 2005). This process
directly influences downstream cellular processes such as ECM production, proliferation,
differentiation, and survival by affecting the types of proteins activated (Anselme, 2000;
van der Flier and Sonnenberg, 2001; Olivares-Navarrete et al., 2008; Siebers et al., 2005;
Stevens and George, 2005). This is important for implants as it is thought that osteoblast
adhesion is important in determining their long-term viability (Dettin et al., 2001). The
rate at which cells attach to a biomaterial will influence the predominant cell type that
colonizes the surface. Furthermore, rapid cell adhesion may assist in the early
stabilization of the implant, reducing the probability of fibrous capsule formation. One
study comparing titanium plasma sprayed (TPS) and SLA implants showed that the TPS
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surfaces had higher protein adsorption and this resulted in increased cell attachment at
early time points (Galli et al., 2005). Furthermore, a comparison of several commercially
available titanium implants revealed that SLA and TPS had significantly higher adhesion
than the polished and machined surfaces (Passed et al., 2010).

1.6.3.2

Spreading

Osteoblast spreading is influenced by the types of integrin subunits activated during cell
adhesion as well as surface wettability, chemistry, and topography (Anselme, 2000; Zhao
et al., 2007). It has generally been accepted that osteoblasts spread more on smooth
surfaces compared to rougher surfaces, (Anselme, 2000; Galli et al., 2005; Keselowsky et
al., 2007; Liithen et al., 2005; Zhao et al., 2007). Current theories suggest that overall
cell stiffness (Bhadriraju, 2002) plays a role in cell spreading in response to topographical
cues. In particular, it has been shown that by disrupting the actin cytoskeleton, cell
stiffness decreases proportionally (Rotsch and Radmacher, 2000). However, increased
spreading is evident on hydrophilic surfaces independent of the level of roughness
suggesting that cell spreading may be influenced by surface energy and is not completely
defined by the geometrical limitations produced by the topographical features. However,
these factors can be manipulated by coating the surface with other proteins or peptides
(Miron et al., 2010; Schuler et al., 2006).

1.6.3.3

Migration

Recruitment and guidance of cells is one of the most critical events in bone healing
around implanted materials. Most studies on osteoblast migration to date have been
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limited to microfabricated topographies (Owen et al., 2005). It is now well-established
that osteoblasts will show directional migration in response to microgrooves,
discontinuous edged topographies (Hamilton et al., 2006), tapered pits (Hamilton et al.,
2007) and nanotopographies (Lamers et al., 2010). Defined as osteoconduction (Kuzyk
and Schemitsch, 2011), the migration and differentiation of osteoprogenitor cells into
osteoblasts is essential for bone formation in direct apposition to the implant surface.
The specific role of osteoblast migration on implant surfaces, and how it relates to
differentiated function and biomineralization, has yet to be clearly defined. However, it
is clear that osteoblast/osteoprogenitor colonization of the surfaces would be required for
bone formation on the implant.

1.6.3.4

Proliferation

During bone healing and intramembranous ossification, proliferation of MSCs is the first
step leading to osteoblast differentiation (Omitz and Marie, 2002; Smith, 1985).
Proliferation is required for maturation of osteoblast cultures and nodule formation.
Furthermore, downregulation of proliferation promotes differentiation of osteoblasts up
to the point of mineralization (Owen et al., 1990). It has been well established that
surface roughness can influence osteoblast proliferation (Anselme et al., 2000; Galli et
al., 2005; Keselowsky et al., 2007; Martin et al., 1996; Passed et al., 2010; Schwartz et
al., 2001 ; Schwartz et al., 2009; Zhao et al., 2007; Zinger et al., 2005). In these studies,
increasing roughness resulted in a decrease in proliferation. In one study, the a5 integrin
subunit was partially responsible for osteoblast proliferation. However, this was in a
topography-independent manner (Keselowsky et al., 2007).
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1.6.3.5

Differentiation and Biomineralization

Differentiation and biomineralization of osteoblasts on biomaterials is critical to the
success of these materials in bone restoration applications. Although many studies have
demonstrated the influence of surface topography on osteoblast differentiation, the
cellular mechanism causing this remains elusive as many cell processes are regulated by
topography. For many years, it has been known that surfaces with increased roughness
exhibit increased osteoblast differentiation (Galli et ah, 2005; Keselowsky et ah, 2007;
Lincks et al., 1998; Martin et al., 1996; Schwartz et al., 2001; Zhao et al., 2007; Zinger et
al., 2005) and biomineralization (Hamilton et al., 2006; Larsson et al., 1996; Nebe et al.,
2004; Wieland et al., 2005). Furthermore, topographical modifications of multiple sizes
can act synergistically to increase both osteoblast differentiation and mineralization
(Wieland et al., 2005; Zhao et al., 2007). As topography influences both differentiation
and adhesion formation, several studies have investigated the role of adhesion signaling
in differentiation. These studies demonstrated that adhesion signaling can regulate
differentiation (Hamilton and Brunette, 2007; Keselowsky et ah, 2007).

In general, rougher topographies such as SLA have been demonstrated to increase
osteoblast attachment, differentiation, and biomineralization (Bàchle and Kohal, 2004),
whereas smooth topographies promote adhesion formation, spreading, F-actin stressfibre
formation and proliferation. However, the molecular regulation of these observations is
still poorly understood.
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1.6.3.6

F-Actin Organization: Signaling nexus for osteoblast
differentiation in response to topography?

Many studies that have investigated the effect of surface topography on cell response
have demonstrated the influence of the topography on regulating cytoskeletal
organization (Anselme et al., 2000; Kieswetter et al., 1996; Lincks et al., 1998; Liithen et
al., 2005; Nebe et ah, 2004; Wieland et ah, 2005; Zhao et ah, 2007). Only a few studies
recently have begun to investigate the effect of directly manipulating cytoskeletal
reorganization to influence other cell processes (Calzado-Martin et ah, 2011; Higuchi et
ah, 2009; Jung et ah, 2011; Tian et ah, 2009; Wu et ah, 2009; Zhang et ah, 2011). The
proteins involved in cytoskeletal reorganization and F-actin polymerization affect many
cellular processes including migration (Sander et ah, 1999), cell fate determination, cell
polarity, endosome trafficking (Heasman and Ridley, 2008), transcription factor nuclear
translocation (Kawashima et ah, 2006), phagocytosis, activation of reactive oxygen
species (Bosco et ah, 2009), cell cycle progression (Jaffe and Hall, 2005), apoptosis
(Bokoch, 2000) and may be responsible for the observed changes in cellular behaviour
seen on different topographies. The SLA surface reduces F-actin stressfibre formation in
osteoblasts (Passed et ah, 2010; Wieland et ah, 2005) at time points up to 24 hours,
unless the hydrophilicity of the surface is increased (Lai et ah, 2010). In general, as
surface roughness increases, osteoblasts become less able to form focal adhesions (FAs)
and F-actin stressfibres. Interestingly, osteoblast differentiation increases on rougher
surfaces suggesting an inverse correlation between FA formation, F-actin stressfibres and
osteoblast differentiation. Cytoskeletal reorganization, whether influenced by topography
or not, is regulated by the Rho-family of GTPases (Hall, 1998; Nobes and Hall, 1995),
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but their role in topographical induction of osteoblast differentiation has never been
investigated.

1.7

Ras-related Rho GTPases

The ras-related Rho family of GTPases was extensively studied in the late 1980s and
1990s using fibroblasts (Ridley and Hall, 1992; Ridley et al., 1992) in order to elucidate
their roles in cell behaviour. The three most thoroughly studied GTPases are Cdc42,
Racl, and RhoA. These proteins act as molecular switches, which are active when bound
to guanosine 5’-triphosphate (GTP) and inactive when bound to guanosine 5’diphosphate (GDP) (Bokoch, 2000). Several of the effects of these GTPases have been
elucidated, and range from actin polymerization to transcription factor regulation to
mitogen-activated protein kinase (MAPK) pathway and cell-cycle regulation among
others (Bishop and Hall, 2000). Some of their effectors, such as p21-activated kinase
(PAK), are shared by multiple GTPases illustrating the potential cross-talk and
complexity of GTPase signaling (Bishop and Hall, 2000). Actomyosin contractility is
another downstream effect regulated by Cdc42, Racl, and RhoA (Vicente-Manzanares et
al., 2005).

1.7.1

Cdc42

The role of Cdc42 in fibroblasts was first described in 1995 by Nobes and Hall (Nobes
and Hall, 1995). It was demonstrated that Cdc42 was responsible for filopodia formation
and also increased Racl activity which in turn lead to increased RhoA activity (Ridley et
al., 1992). Since its role in actin polymerization was discovered, Cdc42 activity has been
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demonstrated to affect several other cell processes such as migration and cell polarity in
both fibroblasts (Cau and Hall, 2005; Hall and Nobes, 2000) and epithelial cells
(Heasman and Ridley, 2008). Furthermore, Cdc42 has been shown to promote cell
contractility by preventing the deactivation of myosin light chain (MLC) (VicenteManzanares et al., 2005).

1.7.2

R ad

Polymerization of actin at the cell periphery is stimulated by Racl activity and results in
the formation of membrane ruffles (Ridley et al., 1992) independent of RhoA activity
(Rottner et al., 1999). Racl is required for forming new focal contacts at the leading
edge of a migrating cell (Rottner et al., 1999) to promote migration (Fukuyama et al.,
2004; Hall and Nobes, 2000; Ray et al., 2007). Racl may also influence migration
through regulation of PAK which can affect cell contractility (Bokoch, 2000; VicenteManzanares et al., 2005). Racl has previously been implicated in promoting osteoblast
differentiation under different conditions. Ascorbate-induced (Zambuzzi et al., 2009) and
diosmetin-induced (Hsu and Kuo, 2008) in vitro differentiation of osteoblasts requires
Racl activity and may be accomplished through a variety of downstream effectors
(Bosco et al., 2009). In a bone marrow stromal cell line (ST2), Racl has been shown to
regulate gene expression through p-catenin-Wnt signaling (Wu et al., 2009). Few studies
have investigated the specific role of Racl in osteoblasts and the majority of these have
investigated its role in osteoblast cell lines.
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1.7.3

RhoA

The role of RhoA on the regulation of actin dynamics may be the most apparent of the
three GTPases discussed. Activation of RhoA was first linked to stressfibre and FA
formation in 1992 by Ridley and Hall (Ridley and Hall, 1992). Since then, the role of
RhoA has been thoroughly studied in fibroblasts, as well as osteoblasts and monocytes.
The formation of stressfibres is associated with the localization of talin and vinculin to
FAs (Rottner et al., 1999) which arise from Racl-mediated focal contacts. It has been
suggested that these stressfibres may play a role in cytoskeletal tension and retraction of
the trailing edge (Nobes and Hall, 1995). Furthermore, MLC has been implicated in
RhoA signaling as RhoA-protein associated kinase (ROCK) activity prevents MLC
déphosphorylation (Vicente-Manzanares et al., 2005; Zhang et al., 2011), thus increasing
contractility. Deactivation of either RhoA or ROCK leads to increased migration in
fibroblasts (Arthur and Burridge, 2001; Bokoch, 2000), monocytes (Worthylake and
Burridge, 2003), and osteoblasts (Zhang et al., 2011).

1.7.4

Summary

Racl and RhoA are very closely linked GTPases. In fibroblasts they have been shown to
regulate one another in a reciprocal fashion. Furthermore, the activation of Racl or
RhoA ultimately determines the cell shape and migration (Sander et al., 1999). While
studies have suggested that RhoA activity promotes MSC osteogenic lineage
commitment (McBeath et al., 2004; Shih et al., 2011), once the MSCs have committed,
RhoA and ROCK act to inhibit osteoblast differentiation (Chaplet et al., 2004; Harmey et
al., 2004). Thus in order to promote osteoblast differentiation, Racl activation may be
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required. Furthermore, cell shape is also important as osteoblast commitment only
occurred when RhoA was active and MSCs were spread out. This suggests that RhoA
and/or ROCK are involved in signal transduction in relation to cell shape. The role of
these GTPases in topographical signal transduction has been further demonstrated
through the alignment of MSCs and osteoblasts on grooved titanium which could be
significantly reduced through the inhibition of either RhoA or ROCK (Calzado-Martin et
al., 2011). Whether or not Racl and/or RhoA play a role in the regulation of osteoblast
differentiation in response to surface topography has yet to be investigated.

1.8

Hypothesis and Objectives

The functional significance of GTPase activation and F-actin reorganization in
osteoblasts in response to altered topography has never been directly tested. Recent
studies have shown that actin gene expression is downregulated in mineralizing, but not
non-mineralizing, osteoblasts (Alves et al., 2011). Moreover, disruption of F-actin
stressfibre formation using cytochalasin-D results in increased ALP and OC secretion in
MC3T3-E1 murine osteoblasts. However, both these studies were performed on tissue
culture plastic and an understanding of how implant topographies influence osteoblast
differentiation downstream of F-actin reorganization could be of great significance for
dental and orthopaedic implant integration.

1.8.1

Overall Hypothesis

Due to the changes observed in actin polymerization in response to surface topography
and the differences in osteoconductivity of different topographies, we hypothesize that
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GTPase activity is responsible for topography-induced changes in osteoblast
differentiation and mineralization.

1.8.2

Specific Hypothesis and Objectives

Inhibition of Rac1 activity w ill increase adhesion formation and decrease osteoblast
migration and differentiation. Inhibition of the RhoA effector ROCK w ill decrease
adhesion formation and increase migration and differentiation.

To test this hypothesis the following objectives were formulated:

1.

To characterize the influence of Racl on the spreading, adhesion

formation, migration, differentiation and mineralization of primary rat calvarial
osteoblasts (RCOs) on polished titanium (PT) and sand-blasted with large grit and
acid etched (SLA) surfaces.

2.

To characterize the influence of RhoA-ROCK on the spreading, adhesion

formation, migration, differentiation and mineralization of primary RCOs on PT
and SLA surfaces.
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Chapter 2
2

Role of Rac1 and RhoA-ROCK Signaling on Osteoblast
Differentiation on Smooth and Rough Titanium
Topographies

2.1

Introduction

Titanium and its alloys have been used for bone-contacting implants for several decades
due to their high biocompatibility, low corrosion, and lower elastic modulus compared to
other implant materials (Parr et al., 1985). In vivo, titanium forms a direct interface with
bone tissue through the process of osseointegration. By modifying the surface
topography of the implant surface, formation of bone on titanium surfaces can be further
enhanced. Topographical regulation of osteoblast behaviour has been well established in
many studies both in vitro and in vivo, with roughened topographies particularly
osteoconductive. Roughened titanium topographies can be produced through additive
techniques such as titanium plasma spraying or subtractive techniques such as grit
blasting, acid etching or anodization (Le Guehennec et al., 2007). Combinations of these
treatments can also be used, as in the case of the SLA topography produced by grit
blasting followed by acid etching (Junker et al., 2009; Zhao et al., 2005). This technique
results in a surface with hierarchical levels of roughness; large pits 20-50 pm occur as a
result of sand blasting, and smaller micropits 0.5-2 pm in diameter result from
HCI/H2 SO4 treatment (Massaro et al., 2002; Wieland et al., 2005).
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Rougher topographies such as SLA have been demonstrated to increase osteoblast
attachment, differentiation, and biomineralization (Bachle and Kohal, 2004), whereas
smooth topographies promote adhesion formation, spreading, F-actin stressfibre
formation and proliferation. SLA surfaces reduce F-actin stressfibre formation in
osteoblasts (Passed et al., 2010; Wieland et al., 2005) at timepoints up to 24 hours, unless
the hydrophilicity of the surface is increased (Lai et al., 2010). It is evident that cellular
recognition of surface features is extremely complex, and remains as of yet, poorly
understood. Therefore, topographies for promoting osteoblast differentiation and bone
formation may not be optimal. By understanding the molecular regulation of osteoblast
differentiation by substratum topography, the possibility exists to enhance the features
present on implants to promote bone formation.

In general, as roughness increases, osteoblasts are less able to form FAs and F-actin
stressfibres. Interestingly, osteoblast differentiation increases on rougher surfaces
suggesting an inverse correlation between FA formation, F-actin stressfibres and
osteoblast differentiation. F-actin reorganization, whether influenced by topography or
not, is regulated by the Rho-family of GTPases (Hall, 1998; Nobes and Hall, 1995).
Focal contact formation and polymerization of actin at the cell periphery is regulated by
Racl, whereas activation of RhoA is linked to F-actin stressfibres and FA formation
(Ridley and Hall, 1992). RhoA mediation of stressfibre formation is associated with the
localization of talin and vinculin to FAs (Rottner et al., 1999) which arise from Raclmediated focal contacts, illustrating the cross-talk and complexity of GTPase signaling
(Bishop and Hall, 2000). Based on their apparent function, these GTPases may be
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responsible for the observed changes in osteoblast behaviour seen on smooth and rough
topographies.

The functional significance of GTPase activation and F-actin reorganization in
osteoblasts in response to altered topography has never been directly tested. Recent
studies have shown that actin gene expression is downregulated in mineralizing, but not
non-mineralizing osteoblasts (Alves et al., 2011). Moreover, disruption of F-actin
stressfibre formation using cytochalasin-D results in increased ALP and OC secretion in
MC3T3-E1 murine osteoblasts (Higuchi et al., 2009). However, both these studies were
performed on tissue culture plastic and an understanding of how implant topographies
influence osteoblast differentiation downstream of F-actin reorganization could be of
great significance for dental and orthopaedic implant integration.

The aim of this study is to assess how pharmacological inhibition of Racl and RhoAROCK signaling influence the adhesion, spreading, F-actin organization, migration,
differentiation, and mineralization of RCOs cultured on smooth and rough titanium
topographies.

2.2
2.2.1

Materials and Methods
Preparation of Titanium Surfaces

SLA and PT Ti discs were prepared as previously described in Miron et al (Miron et al.,
2010). Briefly, PT surfaces (Figure 7A) were prepared using dilute nitric acid to clean
the surface, followed by washing in reverse osmosis-purified water. SLA surfaces
(Figure 7B) were prepared by blasting the Ti with corundum particles, followed by
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etching with HCI/H2SO4. The preparation of each surface as well as the topographical
and chemical properties of these surfaces has been described in detail by both Rupp et al
2006 (Rupp et al., 2006) and Zhao et al 2007 (Zhao et al., 2007).

2.2.2

Osteogenic Cell Culture

All studies involving rats were performed in compliance with the University Council on
Animal Care at the University of Western Ontario under approved protocols. RCOs were
isolated from 0-5 days old Sprague Dawley® rats by enzymatic digestion as previously
described (Hamilton et al., 2007; Hamilton et al., 2006; Miron et al., 2010). Briefly,
parietal and occipital bones were dissected, minced and 700 units/ml of type I
collagenase (CO 130, Sigma-Aldrich, St. Louis, MO, USA) used to release the RCOs from
the bone, with the first supernatant discarded. Cells were plated in tissue culture flasks
using a-MEM supplemented with antibiotics and antimycotics (100 pg/ml penicillin G,
50 pg/ml gentamicin, 25 pg/ml amphotericin B) and 10% fetal bovine serum (FBS;
Gibco, Grand Island, NY, USA)). Cultures were maintained in a 5% CO2 atmosphere
with 100% relative humidity at 37°C.

For experiments, cells were released from 75 cm tissue culture plastic flasks using a
0.05% trypsin and 0.2g/L EDTA-4Na solution and counted using a Beckman Coulter™
Multisizer™ 3 Coulter Counter® (Mississauga, Ontario, Canada). RCOs were seeded at
3 X 104 cells/cm2 for real-time RT-qPCR analysis and at 1 X 104 cells/cm2 for
immunofluorescence.
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Figure 7 - SEM of PT and SLA topographies: PT and SLA surfaces have different

degrees of roughness. A) The PT surface has a relatively smooth topography. B) The
SLA surface possesses large pits (20-50 pm in diameter) caused by sandblasting and
smaller pits (0.5-2 pm in diameter) superimposed by acid etching.
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For experiments lasting longer than 24 hours, cells were supplemented at seeding with 50
mg/ml of ascorbic acid (AA) and 2 mM P-glycerol phosphate (BGP) to induce
differentiation. To assess bone nodule formation, tetracycline (Sigma-Aldrich) was
added to the media at 5 pg/ml.

2.2.3

Inhibitor Studies

Racl activity was inhibited using NSC23766 (Tocris Biosciences, Ellisville, MO, USA)
reconstituted in sterile water and used at a final concentration of 100 pM. RhoA was
inhibited using Y-27632 (Cayman Chemical, Ann Arbor, MI, USA), which blocks Rhoprotein associated kinase (ROCK) which is downstream of RhoA activity (Bishop and
Hall, 2000). Y-27632 was reconstituted in dimethyl sulfoxide (DMSO) and used at a
final concentration o f 10 pM. The NSC23766 and Y-27632 inhibitors were added at the
time of cell seeding and media were changed daily to ensure continuous activity of the
'n

inhibitors.
V

2.2.4

Fluorescent Microscopy

Cells designated for immunofluorecent labeling were fixed in 4% paraformaldehyde in
phosphate-buffered saline (PBS) and permeabilized with 0.1% Triton-X 100 in PBS for
five minutes. Non-specific antibody interactions were blocked using 3% bovine serum
albumin (BSA) in PBS for 30 minutes prior to the addition of the primary antibody.
Samples were incubated with primary antibodies to vinculin (MAB3574, Millipore,
Temecula, CA, USA) at a 1:100 dilution. All antibodies were diluted in 3% BSA in PBS
After a 1 hour incubation with the primary antibody, the surfaces were rinsed three times

73

and then incubated with a 1:200 dilution of Alexa Fluor® 488 goat anti-mouse IgG
(A11001, Invitrogen Canada Inc., Burlington, ON, CAN) for visualization of the primary
antibody and a 1:100 dilution of Rhodamine phalloidin (R415, Cytoskeleton Inc.) for
visualization o f filamentous actin. Nuclei were counterstained using 4 ’,6 diamidino-2phenylindole (DAPI) using Vectashield Mounting Medium (Vector Labs, Burlington,
Ontario, Canada). To visualize bone nodule formation by tetracycline incorporation, an
illumination wavelength of 488 nm was used as previously described (Perizzolo et al.,
2001). Images were captured from each surface on an AxioScope fluorescence
l
microscope (Carl Zeiss Canada, Toronto, ON, CAN) using an Axiocam digital camera
and Axiolmager software. For quantification of cell spreading, images were thresholded
and the planar area of the cells was measured using Axiovision Software Release 4.8.O.O.
To assess FAs, images were exported in the Tagged Image File Format (TIFF). Images
were thresholded to quantify the size and number, of FAs using ImageJ (National
Institutes of Health, Bethesda, MD, USA).

2.2.5

-

Real-time RT-qPCR Analysis

Total RNA was extracted using TRIZOL® reagent at 1 and 7 days according to the
manufacturer’s recommendations. The OC (Bglap, Rn01455285_gl), probe was
obtained from Applied Biosystems™ (Carlsbad, CA, USA). RT-qPCR was run on the
extracted RNA using a final reaction volume o f 15 pi per well. TaqMan® One-Step RTPCR Master Mix Reagents is added to 50 ng of RNA per well in order to obtain the final
reaction volume. Each well contained RNA from one titanium surface. All experiments
were completed in quadruplicate and repeated three independent times. Gene expression
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levels were reported relative to 18S levels and normalized to day 1 PT control cells. Data
were analyzed via two-way ANOVA with a Bonferroni post-test, using Graphpad
Software version 5.00 (Graphpad Software, La Jolla, CA, USA).

2.2.6

Migration

Osteoblast migration was evaluated on PT and SLA surfaces using CellTracker™ Orange
CMTMR (5-(and-6)-(((4-chloromethyl)benzoyl)amino)tetramethylrhodamine) - mixed
isomers (Invitrogen). CellTracker™ was added at 5 pM to a suspension of cells with a
density of 1X104 cells/ml. The suspension was incubated at 37 °C for 30 minutes. The
cells were centrifuged and resuspended in fresh media containing 10% FBS. This
suspension was incubated at 37 °C for a further 30 minutes. 1 ml of this suspension was
then seeded on each surface and the cells were left overnight to attach to the surface.
Inhibitors were added to the media 6 hours prior to video capture. To capture the images,
each surface was inverted into a glass-bottomed petri dish (MatTek®; Ashland, MA,
USA) with fresh media and inhibitors where appropriate. Images were taken using a
Rhodamine filter every 5 minutes for 6 hours.

2.2.7

Quantification of Mineralization

After cell fixation, surfaces were rinsed and dried overnight. They were subsequently
stained with alizarin red for 10 minutes, and rinsed to remove all the unbound dye. The
surfaces were left to dry overnight. The next day alizarin red dye was extracted using
hydrochloric acid for 20 minutes. Absorbance was measured at 415 nm using a plate
reader to determine dye concentration.

s
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2.2.8

Scanning Electron Microscopy/Energy Dispersive X-ray
Spectroscopy

Titanium samples were rinsed in distilled water three times and dried overnight in
preparation for Scanning Electron Microscopy (SEM) and Energy Dispersive X-ray
Spectroscopy (EDX). Samples were imaged at a working distance of 16.0 millimeters
and at 25.0 kilovolts.

2.2.9

Statistical Analysis

Cell spreading and morphology experiments were repeated three times with at least
triplicates within each experiment. Adhesion formation experiments with the Racl
inhibitor were also completed three times with triplicates; however adhesion formation in
the presence of the RhoA-ROCK inhibitor was completed twice with triplicates. The
migration assays were performed twice with 25 cells tracked per surface per 6 hour
experiment. RT-qPCR experiments were repeated three times with ijour replicates per
experiment. Tetracycline experiments were completed once with four replicates. SEM
and EDX analysis were completed on three independent samples from the mineralization
experiment. Two-way ANOVA was used as the statistical test with a Bonferroni posthoc test. All statistical analysis was performed using Graphpad Prism version 5.00 (La
Jolla, CA). p-values < 0.05 were considered significant.
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2.3
2.3.1

Results
Effect of R a d and RhoA-ROCK Activity on F-Actin
Organization on PT and SLA

RCOs cultured on PT and SLA exhibited changes in their morphology and F-actin
arrangement in response to the surface topography. After 24 hours, osteoblasts on PT
displayed prominent stressfibres and had a polygonal appearance (Figure 8). RCOs
cultured on SLA did not display stressfibres, but numerous lamellipodia were evident.
Intense F-actin stressfibres were present along the edges of the cells between sites of
adhesion. The presence of stressfibres on PT, but not on SLA suggests that RhoA is
regulating F-actin assembly on PT at 24 hours, while R a d is active on SLA. At 1 week
post seeding, RCOs formed confluent layers and F-actin stressfibre bundles were
prominent in RCOs on both PT and SLA topographies.

\
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Figure 8 - Organization of F-actin on PT and SLA: Osteoblasts cultured on PT and

SLA display altered organization of F-actin after 24 hours. Osteoblasts form stressfibres
on PT, but not on SLA. On SLA, actin organization is disrupted; however cells form
microspikes around their edges. At 1 week, stressfibres form on both surfaces as they
form multilayers.

\
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2.3.2

Effect of Rac1 and RhoA-ROCK on RCO Morphology and
Spreading

We investigated whether morphology of RCOs on SLA and PT surfaces can be
modulated independently of the topography through the inhibition of either Racl or
RhoA-ROCK signaling (Figure 9A). Racl inhibition increased the intensity of F-actin
stressfibres on PT, whereas RhoA-ROCK inhibition almost completely abolished the
presence of stressfibres on PT. RhoA-ROCK inhibition increased membrane protrusion
and cell elongation on both PT and SLA. In the controls, cells cultured for 24 hours on
PT exhibited significantly higher spreading than those on SLA (Figure 9B) (p=0.0021).
Racl inhibition had no significant effect on the average planar area of the RCOs on either
surface type (Figure 9B).

2.3.3

Effect of Racl and RhoA-ROCK on Focal Adhesion
'n

Formation

^

FA formation was influenced by surface topography, as well as Racl and RhoA-ROCK
inhibition (Figure 10A). FAs identified using vinculin antibodies, were mainly localized
to the periphery of the cell at the ends of filopodia and stressfibres on RCOs cultured on
PT. On SLA FAs were less present in cells, with vinculin observed to be diffuse
throughout the cytoplasm. Within FAs, vinculin staining was more intense in cells on PT
than in cells on SLA. FAs were both larger (pcO.OOOl) and more numerous (p=0.0007)
on PT compared to those on SLA.
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Figure 9 - Osteoblast Planar Area: A) After 24 hours of culture, osteoblasts spread

significantly more on PT than on SLA. Racl inhibition and RhoA-ROCK inhibition does
not significantly affect osteoblast spreading on either PT or SLA. Racl inhibition
increases stressfibre prominence on PT. RhoA-ROCK inhibition abolishes the presence
of stressfibres on PT and results in increased cell extensions. Cells were stained with
Rhodamine phalloidin to visualize the F-actin. B) Graphs represent mean ± SE of 3
independent experiments completed in triplicate. Treatments were analyzed via two-way
ANOVA with a Bonferroni post-test (# denotes significance between PT and SLA,
p<0.05).
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Figure 10 - Focal Adhesion Formation: A) FA size and number are higher on PT than

on SLA after 24 hours of culture. Cells were stained for vinculin (green), F-actin (red),
and nuclei (blue). B) Racl inhibition does not affect FA formation on either surface.
Graphs represent mean ± SE of 3 independent experiments completed in triplicate. C)
RhoA-ROCK inhibition significantly reduces FA number on PT and size on both PT and
SLA. Graphs represent mean ± SE of 2 independent experiments completed in triplicate.
Treatments were analyzed via two-way ANO VA with a Bonferroni post-test (# denotes
significance of p<0.05 between PT and SLA, * denotes significance of p<0.05 between
treatments within a surface type).
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Racl inhibition did not affect FA size or number on either surface topography (Figure
10B) (p>0.05). Inhibition of RhoA-ROCK activity significantly decreased the number of
FAs on PT only (p<0.01), but significantly decreased the size of FAs on both PT
(p<0.001) and SLA (pcO.OOl) (Figure IOC).

2.3.4

Effect of Rac1 and RhoA-ROCK on RCO Migration

RCO migration was evaluated on PT and SLA in subconfluent cultures in the presence of
Racl and RhoA-ROCK inhibitors. Inhibition of Racl activity reduced the rate of RCO
migration compared to control cells on SLA but not PT (p<0.05) (Figure 11A).
Furthermore, an interaction effect was observed between the surface type and the
inhibitors (Figure 1IB). RhoA-ROCK inhibition did not significantly affect migration
rates compared to control cells on either surface type, but the cells developed long
filopodia-like processes. This led to the elongated, osteocyte-like morphology observed
when RhoA-ROCK was inhibited on PT and SLA (Figure IOC). Under RhoA-ROCK
inhibition, filopodia extensions rapidly formed and disassembled moving in various
directions. Lamellipodia extension was not affected by either the Racl or RhoA-ROCK
inhibitors.

2.3.5

Effect of Racl and RhoA-ROCK on Osteocalcin mRNA

The relative gene expression of OC of RCOs was assessed at 1 and 7 days (Figure 12).
OC was significantly upregulated at day 7 as compared to day 1 expression levels
independent of the surface topography (Figure 12A, B) (p<0.0001).
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Figure 11 - Osteoblast Migration: A) Racl-inhibition significantly reduces osteoblast

migration on PT, but has no effect on SLA. RhoA-ROCK-inhibition has no effect on
osteoblast migration. Osteoblast membranes were labeled with CellTracker™ Orange
and images were taken every five minutes for six hours. Graphs represent mean ± SE of
two independent experiments with 25 cells measured per condition. * denotes
significance of p<0.05 between treatments within a surface type. B) A significant
interaction effect was observed between the surface topography and the Racl inhibitor
(p<0.05). C) Images taken from the migration videos at the start of observation, 2 hours,
and 4 hours later. Observation began 6 hours after the addition of the inhibitor. The
morphology of osteoblasts on PT was changed by the ROCK-inhibitor to give a more
elongated appearance. On SLA, there was no major change in cell shape. Bar = 50 pm

86

87

■

V

Figure 12 - Influence of Rac1 and RhoA-ROCK signaling on osteocalcin mRNA
levels: R a d and RhoA-ROCK significantly affect osteoblast transcription of OC. After

1 and 7 days post-seeding, RNA was extracted and real-time PCR was run using a primer
specific for OC. Levels were normalized to the 18S ribosomal RNA. A) Racl-inhibition
significantly reduces OC levels on SLA after 7 days compared to SLA surfaces without
inhibitors. B) RhoA-ROCK-inhibition increases OC mRNA levels on SLA at days 1 and
7 compared to controls.

No significant differences were observed on PT.

Graphs

represent mean ± SE of 3 independent experiments completed with 4 replicates per
experiment. Treatments were analyzed via two-way ANOVA with a Bonferroni post-test
(# denotes significance of p<0.05 between PT and SLA, * denotes significance of p<0.05
between treatments within a surface type). Days 1 and 7 were analyzed independently.
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Inhibition of RacI activity did not significantly change OC expression on PT after 7 days;
however a significant two-fold decrease in OC expression was observed after 7 days on
SLA (Figure 12A) (p<0.05). When RhoA-ROCK activity was inhibited no significant
change in OC expression occurred on PT at either day 1 or 7. On SLA however, RhoAROCK inhibition significantly increased OC expression over control osteoblasts cultured
on SLA after 1 (p<0.01) and 7 (p<0.01) days (Figure I2B) (p<0.05).

2.3.6

Effect of Rac1 and RhoA-ROCK on Runx2 translocation

After 1 week of culture, Runx2 was translocated to cell nuclei in RCOs cultured on both
PT and SLA, although it was also present in the cytoplasm (Figure 13A). Inhibition of
Racl activity reduced nuclear translocation of Runx2 on SLA, but did not affect
localization on PT. RhoA-ROCK inhibition increased nuclear localization of Runx2 on
SLA over that observed in control osteoblasts (Figure 13B). However when RhoAROCK activity was inhibited, Runx2 was primarily translocated to the nucleus on SLA
\
whereas it was evident in both the cytoplasm and nucleus in RCOs cultured on PT.

2.3.7

Effect of Rac1 and RhoA-ROCK on RCO Mineralization

At 2 and 4 weeks, mineralizing osteoblast cultures showed higher levels of tetracycline
incorporation on SLA than on PT (Figure 14). At 2 weeks, when Racl activity was
inhibited, tetracycline incorporation increased on PT compared to controls. However,
this was largely localized in the cytoplasm of the RCOs. On SLA topographies, Racl
inhibition increased tetracycline incorporation intracellularly and extracellularly
compared to controls. At 4 weeks post seeding, Racl inhibition resulted in reduced
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mineralized nodule formation on PT and SLA compared to controls. RCOs on SLA in
the presence of the Racl inhibitor formed small isolated areas of mineral; however no
large nodules were present. This was confirmed through an analysis of calcium content
through alizarin red extraction which was reduced on SLA compared to controls after 4
weeks (p<0.05) (Figure 14). After 2 and 4 weeks, inhibition of RhoA-ROCK activity,
resulted in the formation of numerous large nodules on SLA and PT. The RhoA-ROCK
inhibitor caused a significant increase in mineral content on SLA at both 2 and 4 weeks
(p<0.05), but had no significant effect on PT surfaces.

2.3.8

Scanning Electron Microscopy/Energy Dispersive X-ray
Spectroscopy

Analysis of the elemental composition of the mineral deposited during RCO
differentiation confirmed the presence of a calcium-phosphate mineral. Deposited
mineral was found in areas around bone nodules and had a smooth and flat appearance
(Figure 16A, Arrow). EDX was used to create an elemental map of 4 week cell cultures.
Analysis revealed co-localization of calcium and phosphorus in bone nodules (Figure
16B). Areas devoid of cells around the nodules revealed high levels of titanium since
they had yet to become mineralized.
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Figure 13 - Runx2 nuclear translocation: Racl and RhoA-ROCK influence

localization of transcription factor, Runx2. A) At 1 week, cells were labeled with DAPI
to detect DNA and specific antibodies to Runx2, which was dectected with a fluorescent
anti-mouse secondary. Runx2 localized in the nucleus in cells on both PT and SLA. B)
Racl-inhibition reduced nuclear localization of Runx2 significantly on SLA compared to
controls although it was still found in the cytoplasm. RhoA-ROCK inhibition increased
nuclear localization of Runx2 on SLA compared to controls although not significantly
\
and it was also found in the cytoplasm. Nuclear localization of Runx2 on PT was
unaffected by the inhibitors. Nuclei are stained blue, and Runx2 is stained red.
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Figure 14 - Osteoblast biom ineralization: Racl and RhoA-ROCK affect osteoblast

biomineralization. Osteoblasts on SLA deposit more mineral than on PT assessed by
tetracycline incorporation and do not contract thus pulling themselves off the surface like
those on PT. The Racl inhibitor reduces osteoblast mineralization on both PT and SLA,
and causes contraction of cells on both surfaces resulting in areas of exposed titanium.
The RhoA-ROCK inhibitor increases mineralization and prevents contraction of the cell
layer. Exposures were reduced at the 4 week time point in order to demonstrate
differences in mineralization. Images are representative of triplicates from one
experiment. Mineralized areas appear white.

94

Rac1 Inhibitor

PT
2w

2w

PT
4w

RhoA/ROCK Inhibitor

95

'

V

Figure 15 - M ineralization Q uantification: Racl and RhoA-ROCK inhibition affect

osteoblast mineralization on SLA, but not PT. A) Extraction of alizarin red from the
mineral after staining illustrated that RhoA-ROCK inhibition significantly increased
biomineralization on SLA at both 2 and 4 weeks (p<0.05). However, on PT there was no
significant effect of Racl and ROCK on biomineralization levels at either time point. B)
An interactive effect was observed at 4 weeks (p=0.0114) between the surface type and
the inhibitors as the SLA surface promoted higher levels of biomineralization in both the
control and with the RhoA-ROCK inhibitor present. Data represents one independent
experiment with three replicates.
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2.3.9

Interaction Effects between Rac1 and RhoA-ROCK Inhibition
and Surface Roughness

Racl activity did not interact with surface topography and FA size (p=0.9893), number
(p=0.7735), or OC mRNA levels (p=0.5494) (Figure 17 and Figure 18). However,
RhoA-ROCK inhibition showed an interaction with surface topography, as it had a small
effect on SLA, but reduced FA number (p=0.0099) and size (p=0.0024) to a greater
degree on PT (Figure 17). An interaction effect was also observed at 24 hours with the
RhoA-ROCK inhibitor and surface topography when evaluating OC expression
(p<0.0056). Expression on SLA significantly increased while on PT there was no
significant change. After 7 days, the interaction effect was lost as the RhoA-ROCK
inhibitor had similar effects on both PT and SLA (p=0.4569) (Figure 18).

V
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Figure 16 SEM and EDX analysis of m ineral deposits: Samples were rinsed in

distilled water three times and left to dry overnight prior to imaging. A) At 4 weeks,
mineral deposition around nodules exhibited a smooth and flat appearance (arrow) B)
EDX of the surface shows co-localization of calcium (green) and phosphorus (blue)
within the bone nodule. Titanium (red) can be seen around the nodule in unmineralized
areas. C) The mineral formed is comprised primarily of calcium and phosphorus
suggesting that it may be HA.
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Figure 17 - Surface Topography and Focal Adhesion Interactions: A) Racl activity

did not significantly interact with surface topography to affect FA count or size. B)
RhoA-ROCK inhibition significantly interacted with surface topography (p<0.05),
decreasing FA count and size significantly on PT but not SLA.
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Figure 18 - Surface topography and osteocalcin m R N A expression interaction: A)

Racl activity did not significantly interact with surface topography to affect OC mRNA
expression at 1 or 7 days B) RhoA-ROCK inhibition significantly interacted with surface
topography at 1 day (p<0.05), as OC expression strongly increased on SLA, but had only
a small increase on PT. At 7 days, no interaction effect was observed as a similar effect
was measured on both PT and SLA.
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2.4

Discussion

Topographical-induced adhesion and morphological changes influence osteoblast
migration, differentiation, and mineralization on titanium (Hamilton et al., 2006; Qu et
al., 1996), but the molecular pathways underlying these observations are still poorly
understood. Osteoblasts cultured on smooth surfaces such as PT form large numbers of
FAs and have well-developed F-actin stressfibres, but show a reduced capacity to
differentiate. Osteoblasts cultured on rough topographies such as SLA show higher
levels of differentiation on rough surfaces such as SLA, but they form relatively few
adhesions and the presence of stressfibre networks is rare. These adhesive and
cytoskeletal differences observed in osteoblasts on PT and SLA surfaces may be
reflective of differences in GTPase activation, with RhoA active on PT and R a d on
SLA. Based on these observations, we hypothesized that R ad and RhoA-ROCK
pathways play a role in the regulation of osteoblast adhesion, spreading, migration,
differentiation and biomineralization.
V
To investigate the roles of R ad and RhoA-ROCK signaling in osteoblast response to PT
and SLA topographies, we utilized the well-characterized pharmacological inhibitors
NSC23766 (R a d ) and Y27632 (RhoA-ROCK), as opposed to genetic deletion or siRNA
knockdown. NSC23766 is a cell-permeable inhibitor of R a d activation through
inhibition of the Rac-specific guanine exchange factors TrioN and Tiam 1, both of which
catalyze GDP/GTP exchange. With regards to specificity, NSC23766 likely also inhibits
Rac2 and Rac3, but Rac2 is mainly expressed in hematopoietic lineages and Rac3 is
associated with neuronal development. NSC23766 has no effect on Cdc42 or RhoA
activation. To inhibit RhoA, we blocked its direct downstream effector molecules
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ROCKs, using Y27632, which is a non-isoform-selective inhibitor that targets the
adenosine tri-phosphate (ATP)-dependent kinase domains of both ROCK1 and ROCK2.
Essentially Y27632 works by competing with ATP for binding to the kinases domains of
the ROCKs. Based on previous studies (Bishop and Hall, 2000; Elias et al., 2010; Gao et
al., 2004; Zimmerman et al., 2004), these inhibitors are specific to delineate the roles of
Racl and RhoA-ROCK in osteoblasts response to alterations in substratum topography.

The most prominent finding from this study is that inhibition of RhoA-ROCK signaling
in osteoblasts significantly increases OC expression on both PT and SLA topographies
and biomineralization on SLA only. This is the first report that inhibition of RhoAROCK signaling in osteoblasts cultured on titanium results in the enhancement of
differentiation and mineralization. Racl inhibition attenuated, but did not inhibit, OC
expression, with a significant reduction in mRNA levels seen only on SLA at 7 days post
seeding. Significant increases in biomineralization were evident at 2 and 4 weeks on
SLA in the presence of RhoA-ROCK inhibitors, as assessed through tetracycline
incorporation and alizarin red extraction, with subsequent EDX analysis confirming the
presence of calcium phosphate. Inhibition of Racl activity reduced nuclear translocation
while RhoA-ROCK inhibition increased nuclear translocation of the OC transcription
factor Runx2 on SLA only. RhoA-ROCK inhibition has been previously demonstrated to
increase OC synthesis and biomineralization of mouse calvarial osteoblasts cultured on
tissue culture polystyrene (Kanazawa et al., 2009). Furthermore, during osteogenic
differentiation of human MSCs on polyacrylamide hydrogels coated with type I collagen
(42.1 ±3.2 kPa), RhoA-ROCK activation was demonstrated to inhibit osteoblast
differentiation (Shih et al., 2011). Therefore, RhoA and its downstream effectors, ROCK
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1 and ROCK 2, appear to negatively regulate osteoblast differentiation, which is
consistent with the findings of our study.

We also observed that RhoA-ROCK inhibition and topography acted synergistically to
significantly increase OC mRNA levels at 24 hours on SLA more so than on PT. This
represents another example of topographical-specific signaling influencing osteoblast
differentiation. We have previously shown that microfabricated topographies that
promote osteoblast differentiation activate focal adhesion kinase and extracellular-signal
regulated kinase 1/2 (ERK1/2) phosphorylation in comparison with cells cultured on nonosteoconductive smooth surfaces (Hamilton and Brunette, 2007). Although the current
SLA topography is one of the most effective topographies for promoting osseointegration
(Bomstein et al., 2005; Cochran et al., 1998; Le Guehennec et al., 2007), our results
demonstrate that considerable enhancements could be made to accelerate bone formation
beyond the effects of the topography alone. We have previously shown that pre
adsorption of enamel matrix derivative (EMD) to PT and SLA topographies enhanced
osteoblast differentiation (Miron et al., 2010). Moreover, the adsorption of the enamel
proteins negated the influence of the topography, with BSP and OC mRNA levels
increased to similar levels in osteoblasts cultured on both EMD-coated PT and SLA.
Therefore, although topographical cues are important determinants of implant integration,
it is clear that protein deposition and soluble factors are required to optimize the rate of
bone formation.

At 7 days post seeding on SLA surfaces, stressfibre bundles are evident, suggesting that
as RCOs become confluent, the topography is less important than cell-cell contacts.
These results also demonstrate that surface roughness itself does not present an absolute
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barrier to osteoblast actin dynamics, rather that surface roughness increases cell
contractility through activation of ROCK1 and ROCK2.

Inhibition of RhoA-ROCK signaling also resulted in a significant reduction in FA
formation. Racl and Cdc42 stimulate the formation of focal contacts, with RhoA-ROCK
regulating the subsequent formation of actin stressfibres bundles and the development of
mature FAs. On SLA surfaces, osteoblasts form many small adhesions, large mature FAs
being relatively rare, with the reverse true for cells cultured on PT surfaces. As
osteoblasts have a higher level of differentiation on SLA topographies, it appears that
formation of mature FAs is not a pre-requisite for osteoblast differentiation. Interaction
effects were seen between substratum topography and RhoA-ROCK inhibitors, a
significant decrease in FA size and number was observed on PT surfaces, but not on
SLA. We have previously shown that FA-mediated signaling is activated on
microfabricated topographies that enhance osteoblast differentiation, but these results
suggest that it is more likely dependent on the activated signaling cascades, rather than
\
the size or maturity of the FAs.

The results of this study demonstrate the antagonistic roles of Racl and the RhoA-ROCK
pathways on osteoblast differentiation and mineralization. We suggest that Racl activity
favours osteogenesis and its inhibition attenuates this effect, but does not inhibit it. RhoA
activity prevents osteoblast differentiation through activation of its downstream effectors
ROCK1 and ROCK2. Increased migration may facilitate quicker formation of bone
nodules, although neither RhoA-ROCK, nor Racl inhibition, influenced proliferation
rates of osteoblasts on either PT or SLA which is a necessary step in nodule formation
(data not shown).
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The effectiveness of RhoA-ROCK inhibition on accelerating osteoblast migration,
differentiation, and mineralization has huge implications not only for enhancing implant
integration, but also for bone tissue engineering applications. In 1986, Bellows et al.
(Bellows et al., 1986) demonstrated the necessity of AA and BGP for matrix secretion
and mineralization of osteoblasts respectively in vitro. Since it was defined, osteogenic
media has consisted exclusively of AA and BGP, although dexamethasone is often also
included as it increases osteoblast differentiation in vitro (Yamanouchi et al., 1997).
Based on the results of this study, we propose that a RhoA-ROCK inhibitor should be
considered as a standard additive to osteogenic media to accelerate bone formation.

One of the major issues facing patient-specific tissue regeneration is the amount of time
required for the patient’s cells to migrate into, proliferate, differentiate, and produce
matrix within a scaffold ex vivo. The use of a RhoA-ROCK inhibitor could accelerate
osteoblast infiltration, differentiation, and mineralization in both ex vivo and in vivo
seeded scaffolds for bone tissue regeneration. This would ultimately reduce the amount
V
of time required to produce patient-specific tissues suitable for implantation.

2.5

Conclusion

We have demonstrated differences in the impact of the cytoskeletal-regulating proteins
Racl and RhoA-ROCK on osteoblast spreading, adhesion formation, migration,
differentiation, and mineralization in response to substratum topography (Figure 19).
While topographical manipulation of Rho-family GTPases can significantly affect bone
regeneration, pharmaceutical inhibition of RhoA-ROCK activity can more effectively
promote osteoblast differentiation and mineralization. Future evaluations o f a material's
ability to induce bone formation may rely on measuring the relative activation of Rac 1

and RhoA-ROCK. Further elucidation of the pathways through which cytoskeletal
changes regulate gene expression in osteoblasts will be instrumental in developing
scaffolds and bioactive materials for bone tissue regeneration in future dental and
orthopaedic applications.
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Figure 19 - Sum m ary of Topography and In h ib ito r Effects: ROCK inhibition on both

PT and SLA have similar effects albeit in a topography-dependent manner leading to
increased mineralization through reduced focal adhesion formation and increased mRNA
levels. The Racl inhibitor did not have any significant effects on PT, wherease on SLA it
reduced migration, Runx2 nuclear localization, and osteocalcin mRNA levels leading to
reduced mineralization.
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3

General Discussion

3.1

Summary and Conclusions

Objective #1 : Identify the role of Rac1 in osteoblast spreading, adhesion formation,
migration, differentiation, and mineralization on smooth and rough titanium
topographies

In this study, inhibition of Racl had no significant effect on osteoblast spreading or
adhesion formation on either PT or SLA topographies. Racl inhibition significantly
reduced migration rates on SLA but not on PT. Differentiation of osteoblasts on SLA but
not PT as evaluated through OC mRNA levels was dependent on Racl activity. Nuclear
translocation of Runx2, the transcription factor for osteocalcin and other bone-specific
extracellular matrix protein encoding genes (Karsenty, 2000), was reduced on SLA when
Racl activity was inhibited. Ultimately, mineralization of osteoblast cultures was greater
on SLA than on PT and was significantly attenuated on SLA topographies through Racl
inhibition.

Objective #2: Identify the role of Rho-protein associated kinase (RhoA-ROCK) in
osteoblast spreading, adhesion formation, migration, differentiation, and mineralization
on smooth and rough titanium topographies

RhoA-ROCK inhibition had no significant effect on osteoblast spreading on both PT and
SLA, yet it significantly reduced vinculin-containing adhesion formation on both
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topographies. After 1 day, RhoA-ROCK inhibition significantly increased OC mRNA
levels on SLA but not on PT. After 7 days, RhoA-ROCK inhibition significantly
increased OC mRNA on both topographies, but with higher levels evident on the
osteoconductive SLA surface. Runx2 nuclear translocation was not affected by RhoAROCK activity on either PT or SLA. Mineralization of osteoblast cultures was also
greater on both surfaces in the presence of RhoA-ROCK inhibition, but was only
significant on SLA. These results demonstrate that although RhoA-ROCK inhibition
increased mineralization on both PT and SLA, as an interactive effect between
topography and mineral levels was observed with SLA being significantly higher.

3.2
3.2.1

Contributions to the Current State of Knowledge
General Significance

The role of implant surface topography in the promotion of osseointegration has been
well documented over the past two decades both in vitro and in vivo. In general,
topographies shown to stimulate osteoblast differentiation and biomineralization in vitro
have subsequently been shown to enhance osseointegration in vivo. Racl and RhoAROCK have been shown to influence osteoblast survival (Yoshida et al., 2009), contact
guidance (Calzado-Martin et al., 2011), migration (Fukuyama et al., 2004; Tian et al.,
2009), differentiation, and mineralization (Harmey et al., 2004; Hsu and Kuo, 2008; Jung
et al., 2011; Ohnaka et al., 2001), but the role of Racl and RhoA-ROCK signaling on the
response of osteoblasts to commercially available implant topographies was unknown. In
this study, we report that inhibition of RhoA-ROCK signaling promotes osteoblast
differentiation and biomineralization on two different types of implant topographies.
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3.2.2

Role of the Cytoskeleton and GTPases in Cell Response to
Topography

Cytoskeletal reorganization is a prominent response of osteoblasts to biomaterials with
varying topographical features (Dalby et al., 2002; Qu et al., 1996; Zinger et al., 2004).
On smooth surfaces, osteoblasts exhibit stressfibre bundles that are multidirectional, but
on microgrooves, F-actin stressfibre bundles develop that are highly aligned parallel to
the long axis of the grooves (Oakley and Brunette, 1993). On rough surfaces however,
osteoblasts typically do not form stressfibre bundles (Anselme et al., 2000; Passeri et al.,
2010; Wieland et al., 2005). The overall significance of cytoskeletal reorganization has
mostly been linked to the process of contact guidance (Calzado-Martin et al., 2011),
rather than cell differentiation. Despite many years of attempting to elucidate the
mechanisms linking changes in surface topography to osteoblast differentiation, no
studies have evaluated whether changes in cytoskeletal organization in response to
altered topography can directly influence osteoblast maturity and subsequent
biomineralization. However, it has been suggested that direct pharmacological disruption
of the actin cytoskeleton promotes osteoblast differentiation (Higuchi et al., 2009). This
thesis has demonstrated that both surface topography and soluble factors play a role in
osteoblast differentiation and mineralization in vitro. Whether new implant surfaces can
promote the same degree of osteoblast differentiation as the inhibitors used in this study
has yet to be established. However, since topographical effects were still observed in the
presence of the Racl and RhoA-ROCK inhibitors (Figures 8, 9, 10, 11, 12, and 14), it is
likely that topography will still play a vital role in achieving optimal osseointegration.
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3.2.3

Role of RhoA-ROCK in Osteogenic Assays

Addition of the RhoA-ROCK inhibitor resulted in rapid nodule formation and
mineralization of osteoblasts cultures in vitro. Mineralization assays used to evaluate
new biomaterials can take as long as 6 weeks, yet with the RhoA-ROCK inhibitor, large
mineralized nodules were seen after only 2 weeks and significant increases in mineral
levels were detected only on the osteoconductive SLA topography. Thus demonstrating
that surface dependent effects were not abolished by the addition of the RhoA-ROCK
inhibitor. Reducing the amount of time required to evaluate mineralizing cultures of
osteoblasts will reduce the chances of bacterial contamination, number of media changes
required, potential of cell layer disruptions, and the general costs associated with longer
culture times. The surface dependent effect of the RhoA-ROCK inhibitor on osteocalcin
transcription after treatment for 24 hours may also be useful for evaluating the
osteoconductivity of a material over much shorter time frames.

3.2.4

RhoA-ROCK Inhibition for Bone Formation/Healing

One of the four paradigms of regenerative medicine involves in vitro expansion and
differentiation of cell cultures prior to surgical implantation (Rabkin and Schoen, 2002).
However, regenerated tissues derived from autologous cells take a significant amount of
time to develop (Braddock et al., 2001; Griffith, 2002). The use of a RhoA-ROCK
inhibitor may allow the acceleration in the time required for development of patientspecific tissue constructs as well as to reduce the costs associated with these procedures.
Alternatively, scaffolds implanted directly into a defect without in vitro cell expansion
may also benefit from a RhoA-ROCK inhibitor. Such an inhibitor delivered to the injury
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site, would reduce the amount of time required for osteoblasts to mineralize and fill the
defect, possibly accelerating stabilization of the injury site and ultimately reducing the
time to functional use.

Fasudil, an established RhoA-ROCK inhibitor has been demonstrated to have acute
vasodilator effects in humans (Fukumoto et al., 2005) and provide benefit to patients with
pulmonary hypertension (Fukumoto et al., 2007). The use of fasudil to promote bone
healing has not yet been studied but since it acts to reduce RhoA-ROCK signaling, it may
be beneficial for bone formation in humans based on the results from this current study..

Accelerating bone healing around dental and orthopaedic implants is of particular
importance in situations where healing is impaired due to systemic conditions such as
diabetes or osteoporosis (Ekfeldt et al., 2001). Administration of a RhoA-ROCK
inhibitor over a 3-month period post-surgery could aid the acceleration of bone
formation, thus reducing healing times. This would be especially important in the area of
dental implants, where a no-stress healing period prevents the use of that implant for
approximately at least 4-6 weeks (Adell et al., 1981; Chan et al., 1997; Roberts et al.,
1984). Furthermore, both dental implants and orthopaedic implants placed using
biological fixation undergo a destabilization dip at 2 weeks post surgery due to
osteoclastic bone resorption, prior to the onset of bone secretion (Deporter et al., 1986;
Kuzyk and Schemitsch, 2011). Therefore, drugs such as fasudil may be able enhance
bone formation earlier, thus reducing the degree of destabilization that occurs.
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3.3
3.3.1

Future Directions
Signaling Downstream of Rac1 and RhoA-ROCK Activity
Regulating Osteoblast Differentiation

We have demonstrated for the first time that both Racl and RhoA-ROCK signaling are
strong determinants of osteoblast differentiation and respond to topographical signals.
These GTPases are known to regulate a large number of proteins including p21-activated
kinase, phospholipase D, and phosphoinositide-3-kinase (PI3-K) (Bishop and Hall,
2000). PI3-K is one of the main downstream effectors of Racl and has been
demonstrated to influence osteoblast migration (Fujita et al., 2004; Fukuyama et al.,
2004) and differentiation (Fujita et al., 2004; Golden, 2004) through Runx2 and Akt.
Furthermore, transfection of osteoblasts with a dominant-negative Racl reduced Akt
phosphorylation (Fukuyama et al., 2004). As this thesis has shown that Racl inhibition
decreases Runx2 nuclear localization, Akt is a likely candidate as a downstream effector
\

involved in the regulation of osteoblast differentiation. To study whether the PI3-K
pathway is playing a role, the PI3-K inhibitor LY294002 could be added to culture media
at a concentration of 12.5 pM. To further elucidate the signaling pathway in play,
osteoblasts could be transfected with a dominant negative Akt protein to determine
whether Akt is involved in osteoblast differentiation.

Other studies have suggested that BMP-2 may be upregulated in response to RhoAROCK inhibition using fasudil. However these studies were conducted using
immortalized cell lines. Osteoblast differentiation of stromal cell lines, C3H10T1/2 and
ST2, was shown to occur through BMP-2 (Kanazawa et al., 2010) and mineralization of
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MC3T3-E1 cells occurred through endothelial nitrous oxide reductase (NOS) and BMP-2
(Kanazawa et al., 2009). BMP-2 levels could be measured through Western blotting in
control conditions and when Racl and RhoA-ROCK activity are inhibited.

3.3.2

Role of Cdc42 in Osteoblast Morphology and Differentiation

Another commonly researched Rho-family GTPase is Cdc42. This GTPase appears to be
active on the osteoconductive SLA topography as indicated by the presence of the many
filopodia (“microspikes”) interacting with the cell’s immediate environment. Inhibition
of RhoA-ROCK causes RCOs to extend large filopodia in many directions suggesting
that in this case Cdc42 plays a larger role in regulating actin dynamics particularly on
SLA. The observed morphology is similar to that of mature osteocytes in culture
(Tanaka-Kamioka et al., 1998; Vatsa et al., 2008) and corresponded to enhanced
osteoblast differentiation and mineralization. Future studies should investigate the role of
Cdc42 in osteoblast differentiation to determine if Cdc42 activity is required for
osteoblast differentiation in response to different types of topography. This could
potentially be investigated in vitro using the recently developed Cdc42 small molecule
inhibitor, secramine A, at a concentration of 50 pM (Pelish et al., 2006).

3.3.3

In vivo Analysis of the Role of GTPases in Secondary

fixation of Titanium Implants
The results from this study clearly show that F-actin organization and activation of Racl
and RhoA-ROCK signaling play a major role in the differentiation of osteoblasts in

123

response to changes in substratum topography in vitro. The next step in the research is to
determine if this translates into changes in bone formation in vivo.

1) Genetic murine models: Long-term studies on the role of Racl and RhoA on osteoblast

differentiation may benefit from Cre-LoxP conditional Racl and RhoA osteoblastspecific knockout mice, as full-body knockouts of these GTPases are embryonically
lethal (Heasman and Ridley, 2008). A LoxP mouse with LoxP sites flanking the Racl
and RhoA genes will be crossed with a mouse that produces Cre-recombinase driven by
the osteocalcin promoter, such that Racl or RhoA will not be transcribed at the point of
osteocalcin production. This would facilitate the study of these GTPases more
effectively and would eliminate any uncertainty surrounding the use of pharmacological
inhibitors with regards to non-specific effects, half-lives, and potential toxicity.

2) Rabbit intercondylar model: The role of Racl and RhoA-ROCK signaling could also

be investigated using the well-established intercondylar model. Implantation of small
titanium rods with different substratum topographies could be placed into skeletally
mature New Zealand rabbits. To inhibit Racl activity in the rabbits, EHT 1864, an
established Racl inhibitor for animal models (Désiré et al., 2005), could be administered
intraperitoneally on a daily basis at 40 mg/kg. Inhibition of RhoA-ROCK activity could
be achieved using fasudil at 10 mg/kg administered orally. Effective inhibition of Racl
and RhoA could be determined using a glutathione S-transferase pull-down to measure
active GTPase levels relative to total GTPase levels determined using western blotting.
At 2, 4, and 6 weeks, bone-implant contact area would be evaluated histologically by
staining with alizarin red S or Von Kossa to visual calcium. Evaluation of bone-implant

contact area at these time points could demonstrate whether these inhibitors influence
osteoblast recruitment and/or bone formation.

3.4

Limitations

As with all scientific studies, there are several limitations to this work. One of which is
the use of pharmacological agents to inhibit Racl and RhoA-ROCK which is not a direct
method of inactivating these proteins. Thus it cannot be stated with full assurance that
these proteins are fully inactivated and that there are no non-specific effects of these
inhibitors. This study makes the assumption that Racl and ROCK activation differ on PT
and SLA based on differences in cytoskeletal organization and actin polymerization. In
order to confirm this, larger titaniums surfaces will be required in order to obtain
sufficient protein to run a GST-pulldown.

3.5

Final Summary

The results from this thesis have demonstrated that Racl and RhoA-ROCK activity and
surface topography play a significant role in osteoblast differentiation and mineralization.
RhoA-ROCK represents a target for accelerating bone formation which has implications
both in the research environment to accelerate in vitro bone formation and in the health
care system. The use of an established RhoA-ROCK inhibitor, such as fasudil, appears
promising for the treatment of bone injuries and disorders. This research suggests that
future implant surface designs should attempt to reduce RhoA-ROCK activation to
accelerate bone formation and mineralization.
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